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Zusammenfassung
In der vorliegenden Dissertation werden statistische Methoden der Datenana-
lyse zur Untersuchung von bedingten und von durchschnittlichen Behand-
lungseffekten entwickelt. Dabei werden Interaktionseffekte von Behandlung
mit Kovariaten explizit beru¨cksichtig. Die Kovariaten ko¨nnen dabei sowohl
manifest als auch latent sein. In vielen Anwendungsfa¨llen werden (durch-
schnittliche) Behandlungseffekte durch einen einfachen Mittelwertsvergleich
der betreffenden Behandlungsgruppen evaluiert. Kovariate werden in Inter-
ventionsstudien miteinbezogen, z. B. um die Effekte der Kovariaten selbst
oder Interaktionseffekte zu untersuchen, um die Teststa¨rke zu erho¨hen oder
(in Feldstudien) um eine mo¨gliche kausale Verfa¨lschung zu adjustieren. Die
hier dargestellten Verfahren ko¨nnen zum Adjustieren von Mittelwertsunter-
schieden verwendet werden, wobei es im Unterschied zu bereits existierenden
Verfahren mo¨glich ist, Interaktionseffekte von Behandlung und Kovariaten
zu beru¨cksichtigen.
Die vorliegende Arbeit beginnt mit einer Definition von durchschnitt-
lichen Effekten. Synonym dazu wird auch der Begriff adjustierter Mittel-
wertsunterschied verwendet um deutlich zu machen, dass eine kausale In-
terpretation nicht unbedingt mo¨glich ist. Fu¨r manifeste Kovariaten werden
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einige der bereits existierenden Verfahren wie ANOVA und ANCOVA ge-
nannt und deren Probleme angesprochen. Lo¨sungen in Bezug einiger dieser
Problem werden aufgezeigt. Es werden neue Verfahren entwickelt, die eine
simultane Analyse von Interaktionseffekten und durchschnittlichen Effekten
gestatten. Die Verfahren werden auch dahin erweitert, dass latente Kovari-
ten in die Analyse mitaufgenommen werden ko¨nnen. Monte Carlo Studien
werden durchgefu¨hrt, die zeigen, dass die entwickelten Verfahren gut fu¨r die
ausgewa¨hlen Beispiele funktionieren. Die entwickelten Verfahren beruhen al-
le auf dem Prinzip der Maximum-Likelihood-Scha¨tzung, wobei nicht-lineare
Bedinungnen auf die Modelparameter bestimmt werden. Es wird ausserdem
gezeigt, wie die Teststa¨rke der entwickelten Verfahren gescha¨tzt werden kann.
Abstract
This dissertation develops statistical methods to estimate and test average
(or main) treatment effects if treatment effects depend on covariates. The
covariates can be manifest or latent. The average effect of a treatment is
usually evaluated by comparing the means of the outcome variable between
treatment groups. Covariates are included in interventional studies for ex-
ample, to study covariate effects or interaction effects, to increase power, or
(in non-randomized designs) to control for causal bias.
This thesis begins with a definition of average treatment effects. The term
adjusted mean difference is used interchangeably in order to emphasis that
the average treatment effect can not be interpreted as the average causal
effect of the treatment without making further assumptions. The existing
methods for manifest covariates and their problems with regard to testing
average treatment effects are discussed. Solutions to some of the problems are
provided. New procedures are developed that allow to simultaneously analyze
interactions as well as average effects. The procedures are then generalized
so that latent covariates can be included in the analysis. Monte Carlo studies
show that they work well for the chosen examples. The developed procedures
are based on maximum likelihood estimation methods involving non-linear
constraints on the model parameters. It is also shown how to estimate power
of the outlined procedures with regard to detecting average treatment effects.
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Chapter 1
Introduction
In the social sciences, researchers are often interested in the effects of a treat-
ment on an outcome variable (also called dependent variable). A frequently
used research design to estimate the effect of the treatment is the treatment-
control group design. The observational units are assigned to either the
group receiving the treatment (treatment group) or the group receiving no
treatment (control group). The effect of the treatment is then estimated by
comparing the group means of the outcome.
Covariates are often included in research designs for several reasons; for
example, to study the effects of the covariates on the outcome, or to study
interaction effects, that is, how the effect of the treatment varies with (or
depends on) the covariates. Covariates may simply be included to gain sta-
tistical power with regard to detecting treatment effects. Including covariates
in research designs where the assignment probabilities of the observational
units are not under control by the researcher (so called observational stud-
ies, see e. g. Rosenbaum, 2002), serves another important purpose, that is,
aiming to statistically adjust for bias with regard to the estimation of the
treatment effect(s). The goal of these statistical adjustment procedures is
1
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to identify the treatment as the cause of differences between treatment and
control group with regard to the estimated outcome.
If interactions between the treatment and the covariates are present, the
researcher will surely want to estimate and test hypotheses about these in-
teraction effects. Even in presence of interaction effects the average effect or
main effect of the treatment might provide useful information. This effect
will be defined in this dissertation. It can be regarded as the overall effect of
the treatment, regardless of the covariates. Estimating and testing this aver-
age treatment effect in presence of interaction effects between treatment and
covariate is the main focus of this dissertation. This dissertation therefore
develops statistical adjustment procedures for the average treatment effects
based on models that include interaction effects between treatment and co-
variates.
For orthogonal factorial designs, ANOVA methods exist that allow to
estimate and test hypotheses about average treatment effects as well as in-
teraction effects. There is no dispute about the methods only about whether
it is meaningful to interpret average effects in the presence of interactions.
This will be a point discussed in this thesis. Another point relates to non-
orthogonal designs. The existing ANOVA methods of partitioning the sums
of squares are still controversial. Particularly misleading is that the different
methods often yield different and sometimes contradictory results (see, e. g.
Overall & Spiegel, 1969; Overall, Spiegel, & Cohen, 1975) and the related
debate in the Psychological Bulletin.
Also, for studies involving continuous covariates ANCOVA and other mul-
tiple linear regression methods have been proposed that are based on cen-
tering the covariates in order to analyze average effects. In this dissertation
it will be shown that centering the covariate on its mean in advance to es-
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timating the model plays an important role with regard to estimating and
testing average treatment effects. The reason for this is that the average
treatment effect is defined based on the mean of the covariate. It will also be
shown however that centering on the covariate mean that is estimated from
a sample leads to a biased estimation of the standard error of the average
treatment effect.
Methods based on the GLM (including ANOVA and ANCOVA) are often
referred to as multiple linear regression and correlation methods. However,
the maximum likelihood (ML) method described in this dissertation can also
be regarded as a multiple linear regression method. Because both methods
are compared to each other throughout this dissertation it is necessary to
distingish between them. Methods based on the GLM assume fixed regres-
sors whereas the described maximum likelihood methods are more general
because they consider stochastic regressors. The values of a fixed regres-
sor are assumed to be fixed, wheres the values of a stochastic regressor are
considered to vary at random. The distinction between fixed and stochas-
tic regressors is not important for the estimation and testing of regression
coefficients and linear combination of these because GLM methods provide
unbiased estimates and tests even for stochastic regressors. The distinction
between fixed and stochastic regressors is important however, for the esti-
mation and the test of average effects. This will be shown in the following
chapter.
If the effect of the treatment varies with covariates, these variables are
also called moderators (see, e. g., Saunders, 1956; Baron & Kenny, 1986).
GLM methods (including ANOVA and ANCOVA) are typically used to an-
alyze these interaction effects, involving the estimation and the testing of
hypotheses about corresponding regression coefficients or linear combina-
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tions of them (see, e. g., Moosbrugger, 1981; Gosslee & Lucas, 1965). Many
textbooks on multiple linear regression include these topics (see,e. g., Cohen,
Cohen, West, & Aiken, 2003; Keppel & Zedeck, 2000).
If interaction effects are present, a major focus of the analysis will be to
estimate and test the conditional effects in order to find out how the effect of
the treatment varies depending on the values of the covariates. Nevertheless,
a researcher might also be interested in the effect of the treatment overall,
that is the main or the average effect of the treatment. For example, in
the context of aptitude-treatment interactions, it is frequently the case that
individuals at different pre-intervention (baseline) levels on the outcome vari-
able benefit differently from the intervention (see, e. g., Cronbach & Snow,
1977). The question whether the average effect of a treatment differs from
zero might be of interest in order to compare different treatments with each
other.
Interventional studies often incorporate a treatment-control group design.
It is common practice to include covariates that are assumed to influence
the outcome variable in order to increase power and to study possible in-
teraction effects. For non-randomized studies it is even more important to
include covariates to explain differences between treatment groups at the
pre-intervention time point (c. f. Cook & Campbell, 1979).
Among the ANOVA approaches and techniques that have been developed
to analyze unbalanced (factorial) designs, four different ways of partitioning
the sums of squares are most commonly used and implemented in many
statistical software packages. They are often referred to as Type I – Type IV
(see, e. g., Searle, 1987; Little, Freund, & Spector, 1991). A problem of
these methods is the difficulty to specify the null hypothesis that is tested,
especially when interaction effects are present. From a theoretical point of
view, none of the hypothesis can be identified as incorrect. They are just
CHAPTER 1. INTRODUCTION 5
different. But it is usually no easy task to identify the most suitable one for
the purposes of a particular study. Different methods may yield different and
sometimes contradictory results (see, e. g. Overall & Spiegel, 1969; Overall
et al., 1975) and the related debate occurring in the Psychological Bulletin.
For a summary see Searle, Casella, and McCulloch (1992) for example.
In the statistics literature the controversy over which are the correct sums
of squares in a two-way, unbalanced, ANOVA model including interaction ef-
fects is not yet settled. Different perspectives and approaches may be found
for example in Snee (1973); M. H. Kutner (1974); Speed, Hocking, and Hack-
new (1978). In this thesis, I outline a method that provides a solution to
this problem; a definition of average treatment effects is given. Hence, the
outlined procedure tests hypotheses that are straightforward to interpret.
ANCOVA methods (see, e. g., Cochran, 1957) have been proposed to in-
clude continuous covariates in the analysis of average treatment effects. A
major drawback of classical ANCOVAmethods is however that possible inter-
action effects are not considered. Aiken and West (1991) proposed a method
that improved the situation considerably. The key is to center the covariates
(see also Marquardt, 1980) and use multiple linear regression methods that
allow to model interactions. Traditionally, such designs were analyzed using
non-optimal adaptations of ANOVA. West, Aiken, and Krull (1996) show
how multiple linear regression can produce all of the information provided
by traditional but less optimal ANOVA procedures, including an analysis of
interaction as well as main (or average) effects. The technique of centering
the covariate in advance to the model estimation has also been adopted for
the analysis of treatment effects that depend on the initial status (i. e. indi-
vidual differences before the treatment) using latent variable modeling (B. O.
Muthe´n & Curran, 1997).
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Based on the theory of causality (Rubin, 1974), the propensity score anal-
ysis (Rosenbaum & Rubin, 1984) was developed to analyze average treatment
effects specifically for non-randomized studies, also called quasi-experimental
designs (see, e. g., Shadish, Cook, & Campbell, 2002) or observational studies
(Rosenbaum, 2002). The main principle of this approach is to include co-
variates that (may) interact with the treatment and on which the treatment
assignment might depend on, in order to adjust for bias of the estimated
average causal treatment effect. It is obvious that the main focus of this ap-
proach is on the average (causal) treatment effect and not on the interaction
effects.
The approach proposed in this thesis yields estimates and tests for both:
the average treatment effect and the interaction effects. Because the existing
multiple linear regression methods are sufficient to estimate and test interac-
tion effects, the focus is on the analysis of average treatment effects. For the
case that interactions are present, it is shown that multiple linear regression
is only applicable to analyze average treatment effect in rare cases. That is,
if the covariate means, that appear in the hypothesis, are known. Because
these covariate means have to be estimated in most studies, the maximum
likelihood method outlined in this thesis is useful to analyze average treat-
ment effects.
Experimental designs that investigate the effect of a treatment may in-
clude covariates in order to study interaction effects and to reduce error
variance. Quasi-experimental studies or observational studies may include
covariates in order to reduce bias with respect to the estimation of (causal)
treatment effects. The maximum likelihood test procedure which will be
described and developed for this context is applicable to each type of these
studies. Studies based on designs without randomization do not yield esti-
mates of the treatment effects that can be interpreted as the causal treat-
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ment effect, at least not without making any further assumptions. Therefore,
I speak of the average treatment effect (or adjusted mean difference) instead
of the average causal treatment effect. Whenever appropriate, references are
given that point to the theory of causality and necessary assumptions that
have to hold in order to interpret the average treatment effect as the average
causal treatment effect in the sense of Neyman (1923) or Rubin (1974).
Throughout this thesis I focus on (a single) continuous outcome variable.
It is clear, however, that methodology for multiple outcomes, including cate-
gorical outcomes, is much needed in practice. Furthermore, the thesis focuses
on categorical treatment variables usually considered in intervention studies.
It should be pointed out that the proposed methods are applicable to ana-
lyze effect of categorical variables in general. Such settings may for example
involve gender differences and differences among populations characterized
by other categorical variables.
Given that interaction effects are present, it is shown that hypotheses
about average treatment effects usually involve the means (i. e. the first
moments) of the covariates. If these means are (considered to be) known,
then existing methods based on the general linear model (GLM) can be
used to test hypotheses about average effects. However, in most cases the
covariate means have to be estimated. It will be shown that GLM methods
are not the method of choice to analyze average effects if the covariate means
have to be estimated. Instead, more general statistical procedures such as
the proposed maximum likelihood methods should be used. The simulation
study described in the following chapter shows this for a simple design.
Chapter 2 starts with an introductory example illustrating some of the
principles of how to define average treatment effects in multiple linear regres-
sion analysis. The concept of average treatment effects is then generalized for
designs, that include more than one covariate. It is shown how to estimate
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and test average treatment effects using the maximum likelihood principle.
An example is given that illustrates how to apply the approach to a non-
orthogonal design. The role of centering the covariates is also discussed by
an example. For each example the implementations in Mplus are provided.
A simulation is described showing that maximum likelihood methods are ap-
plicable to test average (treatment) effects, if the necessary covariate means
have to be estimated. In this case multiple linear regression methods or, to
be more precise, methods based on the general linear model, yield inflated
type I errors depending on the size of the interaction effects.
The concept of average treatment effects is generalized to the case of latent
covariates in chapter 3. Estimating and testing the average treatment effect
is then discussed in the succeeding chapters. Chapter 3.3 treats the case in
which randomization is successfully implemented in the research design. The
proposed solution is based on the general latent variable modeling framework
using the multiple group approach. The key is to use constraints that are
implied by the randomized design. These constraints facilitate the estimation
of the average treatment effect. It is then shown how to compute the power
of the proposed approach in order to detect the average treatment effect.
Chapter 4 treats the case in which randomization is not (successfully)
implemented in the research design. Research based on such designs is some-
times referred to as non-experimental research, quasi-experiments or obser-
vational studies. Two approaches are described for this case and Monte
Carlo studies are conducted in order to obtain a first evaluation of both ap-
proaches. The Monte Carlo studies show for the given examples that both
approaches work well. The conclusion is that the proposed methods succeed
in order to estimate and test average treatment effects even in a latent vari-
able framework where the treatment effect varies with latent covariates. This
was thought impossible for example by Jaccard and Wan (1996, p. 41).
Chapter 2
Average Effects with Manifest
Covariates
2.1 Average Effects
To explain the concept of average effects consider the following simple ex-
ample. The effects of a treatment on a continuous outcome (or dependent)
variable Y are investigated by a study based on a treatment-control group
design. The study includes a continuous covariate Z (e.g. a pretest or a
personality variable). The group that receives a treatment (indicated with
X = 1) is compared to a control group (X = 0) that receives a different
treatment or no treatment at all. The regression equation shall include a
(linear) interaction effect between the treatment and the covariate1
E (Y |X,Z) = β0 + β1Z + β2X + β3ZX. (2.1)
1The regression models are presented as population models throughout this disserta-
tion. In the social sciences literature regression models are usually represented as sampling
models. Equation 2.1 represented as a sampling model (with the usual assumption of i.i.d
sampling) for i = 1, . . . , N observations, can be written as
Yˆi = β0 + β1Zi + β2Xi + β3ZiXi.
9
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Most readers will be familiar with the multiple regression based approach,
often termed moderated multiple regression (Aiken & West, 1991; Jaccard,
Turrisi, & Wan, 1990; Judd & McClelland, 1989; Saunders, 1956), that is
typically used to analyze the data from such a design. It is well known that
β2, the first-order effect of X, should in general not be interpreted as the
main effect or the average effect of X in the presence of a interaction. A first
step to establish the meaning of β2 is to compute the expected outcome for
a given value z of the covariate for each treatment condition, that is
E (Y |X=0, Z=z) = β0 + β1z
E (Y |X=1, Z=z) = β0 + β1z + β2 + β3z,
(2.2)
for control and treatment group respectively.
The difference of these two values is called the conditional effect of the
treatment at the value z of the covariate:
E (Y |X=1, Z=z)− E (Y |X=0, Z=z) = β2 + β3z. (2.3)
It is apparent that β2 represents the conditional effect of the treatment at the
value 0 of the covariate. Thus, the meaning of the covariate value 0 must be
considered in order to interpret β2. Because most psychological scales rarely
have meaningful 0 points, the meaning of β2 is usually limited.
Hence, centering the covariate ensures that the interpretation of the first-
order effect of X will occur at a meaningful value of the covariate. Centering
the covariate can be based on E (Z), the true population mean of the co-
variate, if it is available from census data, for example. Usually however,
centering will be based on Z¯, the sample mean of the covariate. Because this
distinction will be important I denote the centered covariate as Z ′ = Z−E (Z)
or Z∗ = Z − Z¯. Note that E (Z) is a fixed value but Z¯ is a random vari-
able. The values z¯ of this random variable change randomly from sample to
sample.
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Based on Z ′, the regression of Equation 2.1 can be written as
E (Y |X,Z) = β′0 + β′1Z ′ + β′2X + β′3Z ′X (2.4)
with
β′0 = β0 + β1 E (Z) β
′
1 = β1 (2.5)
β′2 = β2 + β3 E (Z) β
′
3 = β3. (2.6)
For a given value of Z¯ = z¯, the covariate centered on the sample mean is
Z∗ = Z − z¯, and the corresponding regression may be written as
E (Y |X,Z) = β∗0 + β∗1Z∗ + β∗2X + β∗3Z∗X (2.7)
with
β∗0 = β0 + β1z¯ β
∗
1 = β1 (2.8)
β∗2 = β2 + β3z¯ β
∗
3 = β3. (2.9)
If the regression is based on the centered covariate, then β′2 represents the
conditional effect of the treatment at the true population mean; whereas, β∗2
represents the conditional effect of X at the sample mean of the covariate.
In both cases, centering the covariate ensures that the interpretation of the
first-order effect of X will occur at a meaningful value of the covariate (see,
e. g., West et al., 1996).
It can also be seen that the first-order effect of the covariate and the
interaction effect remain the same whether centering is applied or not. The
fact that the highest-order effect remains constant across any linear rescaling
of the covariate is well known, whereas other effects generally vary. Methods
based on the GLM can be used to test hypotheses about the regression coef-
ficients. I note in passing that the corresponding t-test of β3 yields constant
results across any linear rescaling of Z.
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The question is, if the first-order effect of the treatment in the regressions
based on the centered covariate (i. e. β′2 and β
∗
2) can be interpreted as the
average treatment effect. To answer this question, I first define the term
average effect of the treatment. Consider the function g1−0(Z) that maps
each covariate value to the conditional treatment effect
g1−0(Z) = β2 + β3Z. (2.10)
This function is called the effect function (see, e. g. Steyer, Partchev, Kro¨hne,
Nagengast, & Fliege, 2007). The covariate is called a modifier. Synonyms
for modifier and effect function are moderator and moderator function (see,
e. g., Saunders, 1956; Baron & Kenny, 1986). The effect function of the
given example shows that the effect of the treatment depends (linearly) on
the covariate.
The average effect of the treatment (with regard to the covariate) for
the regression of the given example is defined simply as the average of the
conditional effects. To be more precise, the average effect (AE ) of treatment
1 vs. treatment 0 on the (expected value of the) outcome variable Y for the
given regression is the expectation of the effect function g1−0(Z):
AE 1−0 = E
(
g1−0(Z)
)
= E
(
β2 + β3Z
)
= β2 + β3 E (Z). (2.11)
Note that the average effect is defined with regard to the given regression
including the covariate Z. For a regression including a different covariate
the average effect might differ. However, if the regression of Equation 2.1 is
causally unbiased (e. g. given a randomized design, or conditional random-
ization on Z), then it can be shown that the average treatment effect is the
same for all (combinations of) possible covariates. Given a non-randomized
design, the regression is causally unbiased for example if Z is the only con-
founding variable. The interested reader is referred to literature on causality
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(e. g. Rubin, 2006). The concept of the average effect as it is defined here is
also described by Angrist, Imbens, and Rubin (1996) in a similar framework.
Rosenbaum (2002, pp. 77–78) describes a method to estimated this average
treatment effect and calls this method adjustment for overt bias. Steyer,
Gabler, von Davier, and Nachtigall (2000) give an in depth discussion on
sufficient conditions implying a regression to be causally unbiased (see also
Steyer et al., 2007; Steyer, Nachtigall, Wu¨thrich-Martone, & Kraus, 2002).
The answer to the question from above can now be given. Distinguished
are two cases: first, the centering is based on the E (Z), the population mean
of the covariate, and second, the centering is based on Z¯, the sample mean
of the covariate.
Centering on the population mean: Comparing the definition of
the average effect of Equation 2.11 with the meaning of β′2 in Equation 2.6
reveals that the first-order effect of X is equivalent to the average effect.
Consequently, the average treatment effect can be estimated by centering
the covariate on the population mean and estimating β′2 using multiple linear
regression. The corresponding t-test of β′2 = 0 can be used to test the null
hypothesis
H0 : AE 1−0 = β2 + β3 E (Z) = 0, (2.12)
stating that no average treatment effect is present.
This test can also be performed with an R2-difference test comparing the
full model against the model without the first-order effect of X. The main
limitation of this approach is that the population mean of the covariate has
to be known in order to perform the centering. As mentioned before, the
population mean of the covariate might be inferred from some census data.
Centering on the sample mean: Comparing the definition of the
average effect of Equation 2.11 with the meaning of β∗2 in Equation 2.9 reveals
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that the first-order effect of X is only equivalent if z¯ = E (Z) (given a non-
zero interaction effect). However, a sample mean z¯ that is used to compute
the centered covariate will almost always differ from the true population
mean E (Z). Hence, β∗2 will almost always differ from the average effect.
The simulation study described later clearly shows the consequences. A
multiple linear regression estimate for β∗2 still yields an unbiased estimate
of the average treatment effect. Yet, the t-test of β∗2 = 0 (as well as the
equivalent R2-test) yields inflated type I errors with regard to testing the
average treatment effect (depending on β3).
The reason for this can be explained with the hypothesis that is tested.
The t-test of β∗2 = 0 does exactly what it is supposed to do. Considering
Equation 2.9 it is testing the hypothesis β∗2 = β2 + β3z¯ = 0. However, this
hypothesis differs from the null hypothesis given in Equation 2.12 depending
on Z¯ = z¯ (and β3). Because the simulation study was designed so that H0
holds, the hypothesis β∗2 = β2 + β3z¯ = 0 almost never holds (given β3 6= 0).
The hypothesis actually changes depending on the sample and its mean z¯.
Testing a hypothesis that does not hold leads to a probability of rejecting
the hypothesis that is larger than the significance level. This can be seen in
the simulation study. Hence, it is inappropriate to test H0 with a t-test of
β∗2 = 0, because this test yields inflated type I errors depending on β3.
So far we have seen that multiple linear regression should only be used
if the centering of the covariate is based on the population mean. Because
the mean of the covariate will rarely be known, a method to test the average
treatment effect is needed if the covariate mean can only be estimated from
the sample. Before I propose a solution to this problem I describe a multiple
linear regression test based on the linear hypothesis that is equivalent to the
centering approach for the given example, yet more flexible as we will see in
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an example later.
Hypotheses about (linear combinations of) regression coefficients can be
tested with the linear hypothesis
Aβ − δ = 0 (2.13)
by specifying a hypothesis matrix A and a vector δ according to β, the
vector of regression coefficients. The corresponding F -test is described in
many textbooks on multiple regression (see, e. g., Fox, 1997; Searle, 1971).
Computer programs for multiple linear regression2 (e. g., R, SAS, S-Plus) that
allow testing linear hypotheses can be used to perform this test.
For the given example, hypotheses about average treatment effects can
be tested with the hypothesis matrix
A =
(
0 0 1 E (Z)
)
(2.14)
against any value of δ. Setting δ = 0 specifies the hypothesis of no average
treatment effect and the corresponding F -test yields exactly the same results
as centering the covariate on the population mean and testing β′2 as described
above. The advantage of the centering approach is of course that no hypoth-
esis matrix has to be specified. The linear hypothesis however, provides more
flexibility. We will later see for example, that the linear hypothesis test can
be applied to designs that include interactions between continuous covariates.
The main limitation is again that E (Z) has to be known in order to
specify the hypothesis matrix. Usually however, only the sample mean Z¯
will be available. For a given sample with Z¯ = z¯ the linear hypothesis test
uses
A =
(
0 0 1 z¯
)
. (2.15)
2It is possible to perform this test with SPSS using the scripting language.
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Because z¯ will deviate to some extent from E (Z), the hypothesis that is
tested is not equivalent to the null hypothesis H0.
The multiple regression methods (centering and the linear hypothesis)
based on the sample mean may lead to potential problems with regard to the
estimation and the testing of hypothesis about average treatment effects. z¯
is treated as a fixed value and not as an estimate for the (unknown) covariate
mean E (Z). In other words, the null hypothesis H0 combines two (unknown)
terms β3 and E (Z) together in a multiplicative way yielding a non-linear
hypothesis. Hence, a statistical test is needed that eliminates the given
limitation of the GLM.
The following outline proposes a maximum likelihood test that involves
non-linear constraints in order to test the null hypothesis H0. For the given
example the unconstrained model of Equation 2.1 is compared to a model
with the non-linear constraint
β2 = −β3 E (Z). (2.16)
The chi-square values of both models are compared by a chi-square differ-
ence test. The implementation in Mplus of the test for the given example
is provided after the general outline of the maximum-likelihood procedure.
Before I describe the general outline of the maximum likelihood test, I would
like to address a question that some readers might raise at this point.
2.2 Simple Group Mean Differences
With regard to the specification of the average treatment effect, some readers
might suggest to take the difference between the mean of Y in the treatment
group and compare it to the mean of Y in the control group (and ignore the
covariate). Given a randomized design this would lead to a causally unbiased
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estimation of the average treatment effect. However, the power of this test
would be less if outcome variance is explained by the covariate. Given a non-
randomized design the mean difference E (Y |X=1)−E (Y |X=0) might not
always be equal to the average treatment effect, a numerical example that is
based on the example above is given in the following section.
In a non-randomized design it might well be that the two treatment pop-
ulations differ with respect to their covariate means. Let the covariate mean
of the control population be E (Z |X=0) = 5.4 and the covariate mean of the
treatment population be E (Z |X=1) = 5.0. For simplicity, let the samples
of each population be of equal size so that the expected value of the covariate
results in E (Z) = 5.2. The regression coefficients of Equation 2.1 shall be
β0 = −8.6, β1 = 1.8, β2 = −1.78 and β3 = 0.4.
Based on Equation 2.11 the computation of the average treatment effect
yields a value of 0.3. The means of Y for the two groups can be computed
as3
E (Y |X=0) = β0 + β1 E (Z |X=0)
= −8.96 + 1.8 · 5.4 = 0.76
(2.17)
E (Y |X=1) = β0 + β1 E (Z |X=1) + β2 + β3 E (Z |X=1)
= −8.96 + 1.8 · 5− 1.78 + 0.4 · 5 = 0.26
(2.18)
The resulting mean difference of E (Y |X=1) − E (Y |X=0) = −0.5 dif-
fers considerably from average treatment effect of 0.3. The sign actually
changes. Holland (1986) called this mean difference the prima facie effect.
The fact that the prima facie effect can be misleading is well known (see,
e. g., Simpson, 1951). In the given example the prima facie effect differs
from the average treatment effect because the groups differ with regard to
the covariate, which itself affects the outcome.
3See the Appendix C.1 for a detailed description about the calculation.
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In a randomized experiment the (population) means of the covariate of
the two groups will be equal, i. e. E (Z |X=0) = E (Z |X=1) = E (Z). As a
consequence, the mean difference
E (Y |X=1)− E (Y |X=0) = β2 + β3 E (Z) (2.19)
will be the same as the average treatment effect. Given a successful random-
ization the average effect can be tested by testing this simple mean difference.
It should be pointed out though that the loss of power might be considerable
if the ignored covariate has a strong effect on the treatment. Including such
a covariate (if available) in the analysis of average treatment effect might
therefore be indicated even if randomization was implemented in the design
of a study.
For the analysis of treatment effects from non-randomized studies it is
even more important to include covariates that explain differences in the
treatment groups. If the treatment groups differ with respect to some covari-
ates as in the last example, and these covariates affect the dependent variable,
then these covariates should be included in the analysis. This adjustment
technique is well known in statistical literature and sometimes referred to as
(statistically) controlling for covariates, or partialling out the effects of the
covariates. This example was given in order to emphasize the distinction
between the average treatment effect and the simple group mean difference.
2.3 Generalizations
The example of the last section included only one (continuous) covariate
and only two groups. In the following section, the concept of the average
treatment effect is generalized for more than two treatments with possibly
multiple (continuous and categorical) covariates.
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Let there be J treatment groups. The treatment variable X takes on the
value X = 1 for control, and X = 2, . . . , X = J for the treatment groups.
The following J − 1 dummy variables are used to identify each treatment:
IX=2, . . . , IX=J indicate with 1 and 0 whether or not the observational unit
is assigned to treatment j, with j = 2, . . . , J . The covariates are summarized
in the vector Z, which needs to be specified in each application.
The regression equation of the outcome variable Y regressed on the treat-
ment and the covariates can generally be written as
E (Y |X,Z) = g1(Z) + g2−1(Z) · IX=2 + · · ·+ gJ−1(Z) · IX=J . (2.20)
The function g1 is called the ordinate function. It can be regarded as
a random variable that maps each (combination of) covariate value(s) to
EX=1(Y |Z), the expected outcome under control. The interpretation of
the functions g2−1, . . . , gJ−1 is straightforward. Each function gj−1(Z) =
EX=j(Y |Z)−EX=1(Y |Z) can be regarded as a random variable that maps
every (combination of) covariate value(s) to the conditional effect of the treat-
ment j given Z = z, which is the difference between the expected outcome
under treatment j and the expected outcome under control. These functions
are called slope or effect functions.
A parametrization of the regression (the ordinate and the effect functions)
is needed for a statistical analysis. Consider the following linear parametriza-
tion
E (Y |X,Z) = z′γ1 + z′γ2IX=2 + · · ·+ z′γJIX=J , (2.21)
which is used in multiple linear regression.
The vector z′ = ( 1 Z1 Z2 . . . ) consists of random variables constructed
from the covariates. The first entry might be dropped if the ordinate and
effect functions do not include an intercept. The components of z may rep-
resent continuous covariates and code (e. g., dummy) variables of categorical
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covariates. Some components might represent products of covariates (or of
their code variables), whereas others might be created by (different) func-
tions of the covariates: covariates raised to a power, and products of these.
The vectors γ1, . . . ,γJ contain the corresponding regression coefficients. This
parametrization is well documented in the literature on multiple linear re-
gression (see, e. g., Cohen et al., 2003; Draper & Smith, 1981; M. Kutner,
Nachtsheim, & Neter, 2004).
To give an example: the regression of Equation 2.1 can be expressed with
z′ = ( 1 Z ), γ1 = ( β0 β1 )
′, and γ2 = ( β3 β4 )
′. The example on center-
ing later in this dissertation includes an interaction between two continuous
covariates, i. e.
z′ =
(
1 Z1 Z2 Z1Z2
)
. (2.22)
2.3.1 Average Effects
Above, it was mentioned that each effect function gj−1(Z) (with j = 2, . . . , J)
can be regarded as a random variable that maps each (combination of) co-
variate value(s) to the conditional effect of the treatment j. The following
definition of average effects is therefore straightforward.
Definition 1. The average effect AE j of treatment j with regard to the con-
trol group X = 1 and the covariate Z is defined as the average of the effect
function gj−1(Z), i. e.
AE j−1 = E
(
gj−1(Z)
)
. (2.23)
Note that the concept of the average effects is not limited to a linear
parametrization that is used in multiple linear regression. If there is no
interaction between a treatment j and the covariates, the function gj−1(Z)
will be a constant. In other words the effect of the treatment j on the outcome
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variable is the same for each (combination of) covariate value(s). It is trivial
that in this case the average effect is equal to this constant effect, and the
model is equivalent to a traditional ANCOVA model.
The definition of the average effect of the treatment is given with re-
gard to the covariates included in the regression of Equation 2.20. Changing
the (combination of the) covariates might very well lead to different average
treatment effects unless the regression in Equation 2.20 is causally unbiased.
As mentioned before the term average effect does not mean that it can be
interpreted as the average causal effect in the sense of Rubin (1974) without
further assumptions. In a randomized experiment, as well as in an experi-
ment with conditional randomization based on the covariates included in the
regression, the average effect is equal to Rubin’s average causal effect. For
conditions that have to hold so that the average effect can be interpreted as
the average causal effect outside of (conditional) randomized experiments,
the interested reader is referred to the literature on causality (see, e. g., Gel-
man & Meng, 2004; Rubin, 1974; Rubin, 1978; Rubin, 2006; Steyer et al.,
2002).
2.4 Estimating and Testing Average Effects
Multiple linear regression can be used to estimate and test hypotheses about
the regression coefficients γ1, . . . ,γJ and compute their confidence intervals.
Interaction effects can be estimated and tested for significance, revealing
detailed information about how a treatment affects the outcome for every
value of the covariates.
For the average effects things are more complicated. Given the linear
parametrization of Equation 2.21 it is straightforward to compute the average
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effect of treatment j as
E [gj−1(Z)] = E (z′γj) =
(
1 E (Z1) E (Z2) . . .
)′
γj . (2.24)
Within the multiple linear regression framework (i. e. the general linear
model), the linear hypothesis provides a way to estimate and test hypotheses
about the average effects. By specifying a linear hypothesis matrix according
to Equation 2.24, hypotheses about the average effects can be tested using
multiple linear regression. An example for a linear hypothesis, the corre-
sponding hypothesis matrix, and references were given in the introductory
example.
The main restriction is that the elements E (Z1),E (Z2), . . . of the hy-
pothesis matrix have to be known. They might be considered to be known
for example, if the whole population is included in the study, or the means
are inferred from some census data or from previous surveys that used quota
samples trying to perfectly reproduce the underlying population. The popu-
lation mean of the covariate is also known if the covariate represents a second
experimental factor in the research design. In this case the researcher has
control of the covariate values. Another way to distinguish between whether
or not multiple linear regression is applicable is to ask the following question:
Would the values in the hypothesis matrix be the same or are they likely to
change (due to the sampling process) in a replication study? If the values in
the hypothesis matrix would be the same in replication studies, then multiple
linear regression is applicable to test the average treatment effect.
Usually however, the means E (Z1),E (Z2), . . . have to be estimated, and
therefore become parameters in the underlying statistical model. Conse-
quently, hypotheses about average effects are not linear. The hypotheses
are non-linear because they include products of model parameters: E (Z1) ·
γj1,E (Z2) ·γj2, . . . . For a simple setting the simulation study described later
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shows that multiple linear regression methods (based on the general linear
model) yield inflated probabilities of Type I errors: the larger the interac-
tions between treatment and covariates, the more inflated the probability of
a Type I error.
2.4.1 Maximum Likelihood Methods
If the means E (Z1),E (Z2), . . . of the covariates, that appear in hypotheses
about average effects (see Equation 2.24) have to be estimated, maximum
likelihood methods can be used to test these (non-linear) hypotheses. This
is usually the case if the covariates are stochastic regressors. The values of
these covariates are not fixed (by the experimenter) but are observed as they
randomly occur and population means of these covariates are not available.
The next paragraphs give an outline of the test.
Consider the following random experiment: i = 1, . . . , N observations are
drawn from a population. For each observation the values of the following
random variables are recorded: z a vector of covariates (as well as numeri-
cal functions of the covariates), the treatment variable X and the outcome
variable Y . The following assumptions are made:
• z has a parametric distribution with a set ρZ of parameters (e. g., if z
is distributed multivariate normally, then the parameter set consists of
the vector of means and the variance-covariance matrix of z).
• The conditional distribution of X given z is parametric with a set ρX
of parameters.
• The conditional distribution of Y given X and z is parametric with a
set ρY of parameters.
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The probability of a single observation pρX ,ρY ,ρZ (xi, yi, zi) can be decom-
posed into: fρZ (zi), the probability of the covariate vector; gρX (xi |zi), the
conditional probability of X given the covariate vector; and hρY (yi |xi, zi),
the conditional probability of Y given treatment and the covariate vector.
If the N observations can be regraded as different independent random
trials, the likelihood of the data is the product of the likelihood of all obser-
vations. The logarithm of this likelihood (log-likelihood) can then be written
as
logL(ρX , ρY , ρZ) =
N∑
i=1
log
(
fρZ (zi)
)
+
N∑
i=1
log
(
gρX (xi |zi)
)
+
N∑
i=1
log
(
hρY (yi |xi, zi)
)
. (2.25)
Because the summands are functions of mutually exclusive sets of parameters
the maximum of the log-likelihood is
max
ρX ,ρY ,ρZ
[
logL(ρX , ρY , ρZ)
]
= max
ρZ
[ N∑
i=1
log
(
fρZ (zi)
)]
+max
ρX
[ N∑
i=1
log
(
gρX (xi |zi)
)]
+max
ρY
[ N∑
i=1
log
(
hρY (yi |xi, zi)
)]
. (2.26)
The set of values ρˆX , ρˆY , ρˆZ , that maximize the log-likelihood are taken as
the estimates for the (unknown) parameters ρX , ρY , ρZ .
A hypothesis about average effects poses a constraint on the parameter
sets ρY , ρZ (see Equation 2.24), because it includes parameters of the covari-
ate distribution and parameters of the conditional distribution of Y given X
and z (some of the regression coefficients). It is therefore possible that max-
imizing
∑
log(fρZ (zi)) leads to suboptimal values of
∑
log(hρY (yi |xi, zi))
and vice versa. Hence, the set of values ρˆ′Z , ρˆ
′
Y that maximize the likelihood
under the constraint will usually differ from the set of values ρˆZ , ρˆY that
maximize the log-likelihood without a constraint.
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However, the choice of the parameter set ρX has neither an effect on∑
log(fρZ (zi)), nor on
∑
log(hρY (yi |xi, zi)). It also does not depend on
the choice of ρX , whether the constraint is fulfilled or not. Consequently,
the constraint can be ignored in order to maximize
∑
log(gρX (xi |zi)). This
implies ρˆ′X = ρˆX , which means the values that maximize
∑
logC(gρX (xi |zi))
under the constraint are the same as in the unconstrained case. Hence, the
maximum of the likelihood under the constraint can be written as
max
ρX ,ρY ,ρZ
[logLC(ρX , ρY , ρZ)] = max
ρX
[
N∑
i=1
log
(
gρX (xi | zi)
)]
+max
ρY ,ρZ
[
N∑
i=1
logC
(
fρZ (zi)
)
+
N∑
i=1
logC
(
hρY (yi |xi, zi)
)]
.
(2.27)
If a hypothesis about average effects is true, then a chi-square distributed
test statistic results by taking twice the difference between the maximum of
the likelihood of the constrained model and the maximum of likelihood of
the unconstrained model:
χ2 := 2
{
max
ρX ,ρY ,ρZ
(
logL(ρX , ρY , ρZ)
)
− max
ρX ,ρY ,ρZ
(
logLC(ρX , ρY , ρZ)
)}
= 2
{
max
ρZ
( N∑
i=1
log
[
fρZ (zi)
])
+max
ρY
( N∑
i=1
log
[
hρY (yi |xi, zi)
])
−max
ρY ,ρZ
( N∑
i=1
logC
[
fρZ (zi)
]
+
N∑
i=1
logC
[
hρY (yi |xi, zi)
])}
.
(2.28)
The degrees of freedom equal the number of average effects occurring in the
hypothesis.
This outline shows that it is possible to test average effects even if the pa-
rameters of the covariate that appear in the hypothesis have to be estimated.
The test is based on the maximum likelihood principle. The maximum likeli-
hood of an unconstrained model is compared to the maximum likelihood of a
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model that has a non-linear constraint posed on some parameters according
to the null hypothesis. The key is that the conditional distribution of X
given the covariates does not have to be considered, which makes it possible
to conduct the test with programs like LISREL (Jo¨reskog & So¨rbom, 1996)
and Mplus (L. Muthe´n & Muthe´n, 2004) that allow maximum likelihood
methods involving non-linear constraints.
2.4.2 Implementation in Existing Software
Using a program such as LISREL or Mplus will result in additional assump-
tions about the distribution of the covariates and the conditional distribution
of Y given X and the covariates. Two models are specified according to the
regression equation — an unconstrained model and a model with (non-linear)
constraints according to the null hypothesis. Instead of taking the difference
between maximum log-likelihood values of the two models, it is also possi-
ble to take the difference between the chi-square values of the two models.
Both differences yield equivalent p values because the chi-square values are
computed using the same baseline model (i. e. the corresponding saturated
model with zero degrees of freedom). The unrestricted model might some-
times even be the baseline model, so that the respective chi-square value will
be zero. In this case, the chi-square value of the restricted model can directly
be taken as the test statistic, and the p value of the restricted model is al-
ready the p value according to the null hypothesis. If the unrestricted model
is not equal to the baseline model, the difference in the chi-square values is
chi-square distributed with the degrees of freedom equal to the number of
constraints, and the corresponding p value has to be computed.
Based on the results from the unconstrained model, it is possible to com-
pute point estimates for the average effects and their standard errors. These
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standard errors can either be requested directly from the program, or they
can be computed using the multivariate delta method (Cox & Hinkley, 1974;
Stuard & Ord, 1994) (the necessary variance-covariance matrix of the in-
volved parameters can be requested from the program).
The procedure above provides not only a test of hypotheses about average
effects. The results from the unconstrained model also provide the estimates
and tests of the regression coefficients and therefore the information about
the interaction effects and the conditional effects. In this way, the outlined
procedure provides an in depth view about how treatments work, yielding
both an analysis of the interaction effects and an analysis of the average
treatment effects. The resulting information is similar to the information
that is provided by an orthogonal design analyzed with ANOVA. However,
the procedure is applicable to a much wider range of designs: non-orthogonal
designs and designs including continuous covariates.
2.4.3 Power Estimation of Average Treatment Effects
A measure of effect size is needed in order to analyze power with regard to
average treatment effects. In a traditional two-group t-test setting, effect size
is typically defined as the treatment and control group difference in outcome
means, divided by a standard deviation based on the pooled outcome variance
(Cohen, 1988). As mentioned before, this (simple) outcome mean difference
can be misleading in non-randomized studies with interaction effects between
treatment and covariates.
It is straightforward to define an effect size for the average treatment
effect that is in line with Cohen: the average treatment effect divided by the
standard deviation of the outcome variable. A possible variation is to divide
the average treatment effect by the standard deviation of the outcome of the
CHAPTER 2. MANIFEST COVARIATES 28
control group. In this way, the control group provides the normative value,
whereas the treatment group variance in part reflects the treatment effect.
Given a measure of effect size, power can in principle be estimated by
carrying out a Monte Carlo study recording the proportion of replications
in which the incorrect model is rejected. However, Satorra and Saris (1985)
proposed a method that provides a major simplification. This method is
especially suitable to estimate the power to detect average treatment effects,
because a hypothesis about the absence of an average treatment effect can be
viewed as a specific misspecification of the model (see also Saris & Satorra,
1993; Saris & Stronkhorst, 1984). This method is described in detail in
section 3.5.
Because the outline of the procedure was done in a general way, the fol-
lowing paragraphs provide examples that show how to apply the procedure
using Mplus in order to test average effects. The examples include the intro-
ductory example, an example of a non-orthogonal design, and an example
that illustrates centering the covariates.
2.4.4 The Test for the Introductory Example
The introductory example included a continuous covariate as well as a treat-
ment and a control group. The regression of Equation 2.1 is repeated here:
E (Y |X,Z) = β0 + β1Z + β2X + β3ZX. (2.29)
The null hypothesis H0 stating that no average treatment effect is present
was given in Equation 2.12, which is repeated here:
H0 : AE 1−0 = β2 + β3 E (Z) = 0 (2.30)
If E (Z) is known, it was shown how multiple linear regression can be used
to test the null hypothesis. It will however often be the case that E (Z) has to
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1 DATA: FILE IS data.dat;
2 VARIABLE: NAMES ARE Y Z X;
3 USEVARIABLES ARE Y Z X ZX;
4 DEFINE: ZX = Z * X;
5 ANALYSIS: TYPE = MEANSTRUCTURE;
6 MODEL:
7 Y ON Z(b1)
8 X(b2)
9 ZX(b3);
10 [Y X ZX];
11 [Z](mZ);
12 MODEL CONSTRAINT: b2 = - b3 * mZ; 
Listing 2.1: Mplus input for the constrained model of the introductory ex-
ample
be estimated and the outlined maximum likelihood procedure has to be used
in order to test the hypothesis. The restricted model with the constraint
given in Equation 2.16 is tested against the unrestricted model using chi-
square difference testing. For the given example, the unrestricted model
is identical to the saturated (or baseline) model that Mplus uses to compute
the chi-square statistic, resulting in a value of zero. Therefore, the chi-square
value of the restricted model directly yields the correct test statistic and the
p value of the output is the probability of the test statistic under the null
hypothesis. The Mplus input for the restricted model is given in Listing 2.1.
The unrestricted model is simply obtained by deleting line 12.
An estimate for the average effect can be computed by applying Equa-
tion 2.11 using parameter estimates from the unrestricted model. The corre-
sponding standard error estimate can either be requested from Mplus directly
or it can be computed using the multivariate delta method (Cox & Hink-
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ley, 1974; Stuard & Ord, 1994; Wasserman, 2004). The necessary variance-
covariance matrix of the parameters can be requested from Mplus 4.
2.5 ANOVA
A key feature of the described maximum likelihood method is to solve a prob-
lem that has puzzled statisticians for decades: the analysis of non-orthogonal
(or in general unbalanced) designs (see, e. g., Carlson & Timm, 1974; Gosslee
& Lucas, 1965; Keren & Lewis, 1976). ANOVA is the technique that is most
commonly used to analyze such designs. Because it is not possible for non-
orthogonal designs to partition the sums of squares as a sum of the factors,
interactions, and error sums of squares, many attempts were undertaken to
find an adequate partitioning (see Searle et al., 1992, for a summary).
Among the approaches and techniques that have been developed, four
different ways of partitioning the sums of squares are commonly used and
implemented in many statistical software packages. They are usually referred
to as Type I – Type IV (see, e. g., Searle, 1987; Little et al., 1991). The major
problem of these methods is often to clearly specify the null hypothesis that is
tested, especially when interaction effects are present. Sometimes the results
may even be contradictory (Overall & Spiegel, 1969; Overall et al., 1975). It
can also be shown that these four types of partitioning the sums of squares
generally do not test the hypothesis of no average effect as specified in this
dissertation (see Wu¨thrich-Martone, 2001, for an example).
Data from non-orthogonal designs may include a (categorical) treatment
variable and some categorical covariates (also called factors) that predict
the outcome variable. The treatment variable and the covariates have to be
4See the TECH3 option in the manual (L. Muthe´n & Muthe´n, 2004)
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coded in an appropriate coding system (see, e. g., Cohen et al., 2003) in order
to apply the outlined method. Dummy coding will be used throughout this
dissertation.
The linear hypothesis of the multiple linear regression approach (i. e. the
general linear model) can be used to test hypotheses about average effects,
in case the covariate means appearing in the hypotheses are known. If these
means have to be estimated from the sample, the maximum likelihood pro-
cedure has to be applied to test these (non-linear) hypotheses.
In this manner the outlined procedure overcomes the problems of the
non-orthogonal ANOVA. According to Definition 1 (and Equation 2.24), the
hypotheses that are being tested are straightforward and do not change de-
pending on the cell frequencies. The following section gives an example how
to test the average treatment effects for a simple factorial design.
2.5.1 A Simple Factorial Design
Consider a hypothetical 3 × 3 factorial design. The factor X represents
three treatment groups. The factor Z represents a categorical covariate with
three levels. The cell frequencies may vary arbitrarily. It actually matters
little to the outlined procedure whether the design is orthogonal or non-
orthogonal, as long as there are sufficient observations in each cell. The
treatment variable X may be dummy coded with IX=1 = 1 for the first
group and 0 else; IX=2 = 1 for the second group and 0 else, consequently
the third group serves as the reference. The covariates may also be dummy
coded with Z1 = 1 for level one and zero else, and Z2 = 1 for level two and
zero else, so that level three serves as the reference5. The regression equation
5Dummy coding was chosen for simplicity. However, every appropriate coding scheme
can be applied. The resulting computation will differ.
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can be written in the following way:
E (Y |X,Z) = β0 + β1Z1 + β2Z2 + β3IX=1 + β4IX=2
+β5Z1IX=1 + β6Z2IX=1 + β7Z1IX=2 + β8Z2IX=2.
(2.31)
To derive the average effects I first specify the conditional regressions for
each group
EGrp1(Y |Z) = β0 + β1Z1 + β2Z2 + β3 + β5Z1 + β6Z2
EGrp2(Y |Z) = β0 + β1Z1 + β2Z2 + β4 + β7Z1 + β8Z2
EGrp3(Y |Z) = β0 + β1Z1 + β2Z2.
(2.32)
Comparing the first two groups against the reference group yields the two ef-
fect functions g1−3(Z) = EGrp1(Y |Z)−EGrp3(Y |Z) and g2−3(Z) = EGrp2(Y |Z)−
EGrp3(Y |Z) as
g1−3(Z) = β3 + β5Z1 + β6Z2 and
g2−3(Z) = β4 + β7Z1 + β8Z2.
(2.33)
The two average effects of treatment one and treatment two (each com-
pared to treatment three) are therefore
AE 1−3 = E
(
g1−3(Z)
)
= β3 + β5 E (Z1) + β6 E (Z2) and
AE 2−3 = E
(
g2−3(Z)
)
= β4 + β7 E (Z1) + β8 E (Z2).
(2.34)
Based on Equation 2.34, it is easy to formulate hypotheses about the aver-
age effects. For example, the null hypothesisH0 stating that no (overall) aver-
age treatment effect is present may be written as: H0 : AE 1−3 = AE 2−3 = 0,
or more specifically
H0 : β3 + β5 E (Z1) + β6 E (Z2) = 0 and
β4 + β7 E (Z1) + β8 E (Z2) = 0.
(2.35)
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The H0 can be tested with the linear hypothesis approach of the general
linear model (multiple linear regression) if E (Z1) and E (Z2) are known. If
they have to be estimated, the maximum likelihood method should be used.
The advantage of the outlined procedures over the different ways of partition-
ing the sums of squares (the non-orthogonal ANOVA approach) is apparent:
a hypothesis (about an average effect) does not change depending on the
cell frequencies. Furthermore, H0 is equivalent to the null hypothesis that is
tested by ANOVA given an orthogonal design. Testing the main (treatment)
effect in orthogonal ANOVA means testing the average (treatment) effect.
If randomization is successfully applied, the resulting average treatment
effect is an unbiased estimate of the average causal effect in the sense of
Rubin. This holds whether the design is orthogonal or non-orthorgonal. If
randomization is not successfully applied then the outlined method tries to
statistically adjust for bias with regard to estimating the average causal effect.
However one can never be certain to achieve correct adjustment because there
might be confounding variables omitted in the analysis (see the literature on
causality, e. g., Steyer et al., 2007; Rosenbaum, 2002).
Again, the question whether multiple linear regression can be used to
test the null hypothesis or whether the maximum likelihood procedure has
to be applied, depends on whether the entries E (Z1) = P (Z = level one) and
E (Z2) = P (Z = level two) are known or estimated. As mentioned before,
these means might be considered to be known in some cases; if the covariate
is under control by the researcher, if the whole population is included in
the study, or if the parameters are inferred from some census data, or from
previous surveys that used quota samples trying to perfectly reproduce the
underlying population. Given that the means are (considered to be) known,
H0 is linear in the model parameters and multiple linear regression can be
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used to test the hypothesis.
However, the covariate means E (Z1) and E (Z2) will often have to be esti-
mated from the sample data and therefore the maximum likelihood method
has to be applied. The Mplus input for the example is provided in Listing A.1
on page 141. Please note again that only the input for the restricted model is
provided. The unrestricted model, just like in the example before, is equiva-
lent to the saturated model tested by Mplus and therefore yields a chi-square
value of zero. Hence, the chi-square value and the p value of the restricted
model directly yield the test statistic and the p value corresponding to the
null hypothesis.
2.6 Centering
In order to estimate and test average effects, centering (Marquardt, 1980)
is a method that was proposed for designs with continuous covariates (see,
e. g., Aiken & West, 1991). As we have seen in the first example, centering
can help to facilitate the analysis of average effects. However, centering may
sometimes lead to additional assumptions that are (simultaneously) tested.
This will be shown with an example adapted from West et al. (1996).
This example includes a design with three treatment groups (X = 0, 1,
2) and two continuous covariates Z1 and Z2 (e. g., a pretest and a personality
variable). In order to analyze the effects of the treatments on the dependent
variable Y , the outcomes of treatment one and treatment two are compared
to the outcomes of the control group (X = 0). Two dummy variables are
used to code the treatment groups: IX=1 = 1, if treatment 1 and 0 else;
IX=2 = 1, if treatment 2, and 0 else. The regression equation is structured
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as
E (Y |X,Z1, Z2) = g0(Z1, Z2) + g1(Z1, Z2)IX=1 + g2(Z1, Z2)IX=2, (2.36)
with the three functions g0, g1−0 and g2−0:
g0(Z1, Z2) = β0 + β1Z1 + β2Z2 + β3Z1Z2 (2.37)
g1−0(Z1, Z2) = β4 + β5Z1 + β6Z2 + β7Z1Z2 (2.38)
g2−0(Z1, Z2) = β8 + β9Z1 + β10Z2 + β11Z1Z2. (2.39)
This results in a regression with second order interactions
E (Y |X,Z1, Z2) = β0 + β1Z1 + β2Z2 + β3Z1Z2
+β4IX=1 + β5Z1IX=1 + β6Z2IX=1 + β7Z1Z2IX=1 (2.40)
+β8IX=2 + β9Z1IX=2 + β10Z2IX=2 + β11Z1Z2IX=2.
The computation of the two average effects is straightforward. The aver-
age effect of treatment 1 vs. 0 and the average effect of treatment 2 vs. 0 are
respectively
E
(
g1−0(Z1, Z2)
)
= β4 + β5 E (Z1) + β6 E (Z2) + β7 E (Z1Z2)
E
(
g2−0(Z1, Z2)
)
= β8 + β9 E (Z1) + β10 E (Z2) + β11 E (Z1Z2).
Because E (Z1Z2) = Cov(Z1, Z2)+E (Z1)E (Z2), the null hypothesis stat-
ing that both average treatment effects are zero can be written as
H0 : 0 = β4 + β5 E (Z1) + β6 E (Z2)
+β7 [Cov(Z1, Z2) + E (Z1)E (Z2)] and
0 = β8 + β9 E (Z1) + β10 E (Z2)
+β11 [Cov(Z1, Z2) + E (Z1)E (Z2)] .
(2.41)
If the means E (Z1), E (Z2), and Cov(Z1, Z2) are known, then the linear
hypothesis test can be used by specifying a hypothesis matrix using these
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means in order to test the null hypothesis. Otherwise, the outlined maximum
likelihood procedure is applicable.
To see if centering facilitates the test of the null hypothesis, consider the
centered6 covariates Z ′1 = Z1 − E (Z1) and Z ′2 = Z2 − E (Z2). The equivalent
regression model to Equation 2.6 is
E (Y |X,Z ′1, Z ′2) = γ0 + γ1Z ′1 + γ2Z ′2 + γ3Z ′1Z ′2
+γ4IX=1 + γ5Z
′
1IX=1 + γ6Z
′
2IX=1 + γ7Z
′
1Z
′
2IX=1 (2.42)
+γ8IX=2 + γ9Z
′
1IX=2 + γ10Z
′
2IX=2 + γ11Z
′
1Z
′
2IX=2.
West et al. (1996) recommended to test the null hypothesis by conducting
an R2-difference test, which compares the full regression of Equation 2.6 to
the restricted model
E res(Y |X,Z ′1, Z ′2) = γ0 + γ1Z ′1 + γ2Z ′2 + γ3Z ′1Z ′2
+γ5Z
′
1IX=1 + γ6Z
′
2IX=1 + γ7Z
′
1Z
′
2IX=1 (2.43)
+γ9Z
′
1IX=2 + γ10Z
′
2IX=2 + γ11Z
′
1Z
′
2IX=2.
Dropping the two terms γ4IX=1 and γ8IX=2 this R
2-difference tests the hy-
pothesis
H ′0 : γ4 = γ8 = 0. (2.44)
To see ifH ′0 is equivalent to theH0, consider the meaning of the regression
coefficients γ4 and γ8. Substituting Z1 = Z
′
1 + E (Z1) and Z2 = Z
′
2 + E (Z2)
in Equation 2.6 and applying some algebra, results in
γ4 = β4 + β5 E (Z1) + β6 E (Z2) + β7 E (Z1)E (Z2) and
γ8 = β8 + β9 E (Z1) + β10 E (Z2) + β11 E (Z1)E (Z2).
(2.45)
This shows that the hypothesis H ′0 is only equivalent to the null hypothesis
H0 if Cov(Z1, Z2) = 0.
6Note that the centering is based the population means E (Z1) and E (Z2).
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Given that there is no covariation between the covariates, the null hypoth-
esis H0 can be tested by a R
2-difference test comparing the model without
the terms IX=1 and IX=2 to the full model. However, if a covariation between
the two covariates is present, then the R2-difference test does not test the
H0. This hypothesis can be tested using multiple linear regression with a
hypothesis matrix that has Cov(Z1, Z2) at the appropriate places.
If the means E (Z1), E (Z2), and the covariance Cov(Z1, Z2) have to be
estimated, and the centering is based on the sample means rather than the
population mean, then the maximum likelihood procedure has to be applied.
The corresponding Mplus input is given in Listing A.2 on page 142. The
input is the same whether the covariates Z1 and Z2 are centered or not. The
covariate means are treated as model parameters in both cases.
This example was given to emphasize that the linear hypothesis is more
flexible than the R2-difference test based on the centering approach, which
is only applicable if there is no covariation between the covariates in the
population. The linear hypothesis test however would still yield inflated
Type-I errors if the covariate means and covariance are estimated. For this
case the maximum likelihood approach is applicable.
2.7 Simulation
It was mentioned before that multiple linear regression methods might have
drawbacks with regard to testing hypotheses about average treatment effects
if interaction effects with the covariates are present, and if the means (and
higher order moments) of the covariate that appear in the hypotheses have
to be estimated.
A Monte Carlo Study is conducted in order to compare the performance
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of multiple linear regression methods to the proposed maximum likelihood
approach. A setting is chosen even simpler than the one of the introductory
example. The data are generated to simulate a study that investigates the
effect of a treatment on a continuous outcome variable Y with a random-
ized and balanced treatment-control group design. The treatment variable
X indicates with one or zero, whether an observational unit is assigned to
the treatment or the control group respectively. A continuous covariate is
included in the study to investigate if the effect of the treatment depends on
Z.
The data for the covariate is generated from a normal distribution with
E (Z) = 0 and V ar(Z) = 4. A sample size of 200 is chosen to resemble
a typical sample size in applied psychological research. For the treatment
variable X a random permutation of 100 zeros and 100 ones is drawn in
order to implement random assignment. The data for the outcome variable
Y = E (Y |X,Z) +  is generated based on the following linear regression
equation:
E (Y |X,Z) = β0 + β1Z + β2X + β3ZX. (2.46)
The values for the error variable  are generated from a normal distribu-
tion with E () = 0 and V ar() = 16. The mean E (Z) = 0 and the regression
coefficients β0 = 0.5, β1 = 1.8, and β2 = 0 are chosen so that the average
effect of the treatment remains zero:
AE 1−0 = E
(
g1−0(Z)
)
= β2 + E (Z)β3 = 0. (2.47)
This is important because the interaction effect β3 varies between the
values 0, 0.5, 1, 2.5, 4, 5, and 10. For each interaction effect value, 1000 data
sets, also called replications, are generated. The average treatment effect is
estimated and tested against zero with the following three methods:
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1. Centering on E (Z), the Population Mean: The values for Z ′ = Z −
E (Z), the covariate centered on the population mean, are computed.
As described in the first example, the test is performed by estimating
and testing the regression coefficient β′2 = β2+β3 E (Z) in the centered
regression model E (Y |X,Z ′) = β′0+β′1Z ′+β′2X +β′3Z ′X against zero
using ordinary multiple regression (i. e. the general linear model).
2. Centering on Z¯, the Sample Mean: The same procedure as in the
previous method is applied to estimate and test the average treatment
effect with the only difference that the centering of the covariate is
based on the sample mean Z¯ of each data set.
3. Maximum Likelihood (ML): The chi-square difference test is performed
as described in the outline of the maximum likelihood test; comparing
the unconstrained model with the model that has a non-linear con-
straint. The Mplus input file for the constrained model is given in
Listing 2.1 on page 29. The estimated values for the average effects
E
(
g1−0(Z)
)
= β2 + β3 E (Z) are computed from the parameter esti-
mates of the unconstrained model. The Mplus input file for the uncon-
strained model is equivalent to the input file of the constrained model
without the constraint. The standard errors are computed using the
multivariate delta method.
The performance of the three methods with regard to analyzing the aver-
age treatment effect is assessed with the following dependent measures. The
average of the estimates across replications is computed in order to assess
estimation bias. Standard error bias is assessed based on the average of the
standard error estimators as well as the standard deviation of average effect
estimators. The latter value is considered to be the population standard error
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because the number of replications is 1000. Standard error bias is estimated
by subtracting the population standard error value from the average stan-
dard error value and dividing this number by the population standard error
value and multiplying by 100. An absolute value larger than 5 is typically
considered to be biased (L. Muthe´n & Muthe´n, 2004). Finally the propor-
tions of significant results at a significance level of α = 0.05 are recorded in
order to show whether the nominal alpha level is met or not.
Table 2.1 on page 41 shows the dependent measures as a function of the
interaction effect. To facilitate the interpretation of the results an effect size
measure for the interaction effect is provided. The effect size is computed
dividing the interaction effect by the population standard deviation of the
outcome variable given control. This standard deviation serves as a constant
norm that is independent from the interaction effect, providing a measure or
effect size that is in line with Cohen (1988).
The average estimates indicate that each method yields an unbiased es-
timate of the average treatment effect. The average standard error of the
maximum likelihood method increases the larger the interaction effect. This
is not the case for the two multiple linear regression methods. The only
method yielding biased standard error estimators is the multiple regression
method using the sample mean of the covariate. Given a small interaction
the standard error bias seems inflated, however it is still below the cut point
(−5). For medium and larger interaction effects the standard error estima-
tors are severely biased; the bias increasing with the interaction effect. As
a consequence of the biased standard errors, the proportion of significant
results fail to meet the nominal alpha level. Instead they increase depending
on the interaction effect.
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Table 2.1
Dependent Measures of the Statistical Methods as a Function of the Inter-
action Effect
Interaction effect
0 0.5 1 2.5 4 5 10
Interaction effect size
Method 0.00 0.09 0.19 0.46 0.74 0.93 1.86
Average estimates
E (Z) 0.01 0.00 0.02 0.01 0.00 −0.01 −0.02
Z¯ 0.01 −0.00 0.02 0.01 −0.02 −0.03 −0.03
ML 0.01 −0.00 0.02 0.01 −0.02 −0.03 −0.03
Average standard errors
E (Z) 0.57 0.57 0.57 0.57 0.57 0.57 0.57
Z¯ 0.57 0.57 0.57 0.57 0.57 0.57 0.57
ML 0.57 0.57 0.58 0.67 0.80 0.90 1.51
Standard error bias
E (Z) −1.90 −0.04 −0.61 1.71 3.48 −1.92 0.30
Z¯ −1.61 −0.52 −4.01 −14.14 −26.73 −37.63 −63.09
ML −1.84 0.12 −1.22 1.16 3.61 −0.65 −1.33
Proportion of significant tests
E (Z) 0.05 0.06 0.06 0.04 0.04 0.06 0.05
Z¯ 0.05 0.06 0.06 0.10 0.15 0.23 0.47
ML 0.05 0.06 0.06 0.06 0.04 0.05 0.04
Note. Replications = 1000; N = 200. Bold: Standard error bias values below the
nominal value −5 as well as proportions of significant tests differing significantly
from the expected value of .05 (at a confidence level of .95 based on the exact bi-
nomial test).
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2.8 Empirical Example: Effects of Insulation
on Gas Consumption
A simple example will be used to illustrate the main ideas of this chapter. In
the 1960’s Derek Whiteside of the UK Building Research Station recorded the
weekly gas consumption and average external temperature at his own house
in south-east England for two heating seasons. The first heating season was
26 weeks before cavity-wall insulation was installed, and the second heating
season was 30 weeks after cavity-wall insulation was installed. The object of
the exercise was to assess the effect of the insulation on gas consumption.
The data set is reported by Hand, Daly, Lunn, McConway, and Ostrowski
(1994) and is available from the statistical programing environment R (R
Development Core Team, 2006)7. The data set has 56 observations on the
following three variables:
• Insul: A dichotomous variable, indicating whether the data were recorded
before or after insulation. This variable corresponds to the treatment
variable in the framework here.
• Temp: Purportedly8 the average outside temperature in degrees Cel-
sius. This variable corresponds to the covariate in the framework here.
• Gas: The weekly gas consumption in 1000s of cubic feet. This variable
corresponds to the outcome variable in the framework here.
7The data frame is included in the MASS package under the name whiteside.
8It is noted in the description of the data set of the statistical programing environment
R that the values are too low for any 56-week period in the 1960s in South-East England.
It might be the weekly average of daily minima.
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Figure 2.1: Gas consumption as a function of outside temperature
before and after insulation was installed.
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Table 2.2
Summary of the Regression Analysis Including the
Centered Outside Temperature.
βˆ SE t
Intercept 4.937∗∗ 0.064 76.848
Tempc −0.393∗∗ 0.022 −17.487
IAfter −1.568∗∗ 0.088 −17.875
IAfterTempc 0.115
∗∗ 0.032 3.591
Note. R2 = .93. ∗p < .05. ∗∗p < .01
In Figure 2.1 the gas consumption is plotted against the outside temper-
ature before and after the insulation. The figure also shows the estimated
linear regression functions before and after the insulation, which appear to
fit the data well. The relationship between gas consumption and outside
temperature seems to be linear both before and after the treatment (for the
considered range of temperature values). The slope of both regression lines
is different before and after the insulation indicating an interaction between
insulation and temperature.
As described previously, the covariate (here the outside temperature) is
centered in order to facilitate the interpretation of the subsequent multiple
regression analysis. The sample mean of the outside temperature (before and
after the insulation) is Temp = 4.875. Hence, the centered covariate is
TempC = Temp− Temp. (2.48)
Using ordinary least squares estimation the following regression equation is
fitted to the data
E (Gas | Insul, Temp) = βo+ β1TempC + β2IAfter+ β3IAfterTempC . (2.49)
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The results are given in Table 2.2. The overall model fit is very good
with R2 = .93. The estimated regression coefficient of the interaction term
is 0.12 and significant at the .1 level. The effect size of the interaction is
computed by taking the estimated regression coefficient of the interaction
divided by the variance of the gas consumption before insulation. The value is
0.1 which is considered a small effect following Cohen’s (1988) classification.
The interaction indicates that the observed reduction in gas consumption
after insulation is larger the colder the outside temperature becomes.
The estimated regression coefficient β2 = −1.57 can be interpreted as
the predicted difference between the gas consumption after insulation and
the gas consumption before insulation for the mean outside temperature of
4.875. The corresponding hypothesis test indicates a rejection of the null
hypothesis stating that the difference in gas consumption at the sample mean
of the outside temperature is zero.
A second regression analysis based on the regression in Equation 2.49
but with the un-centered outside temperature was conducted. The following
linear hypothesis (
0 0 1 Temp
)(
β0 β1 β2 β3
)′
= 0. (2.50)
was applied. The tested hypothesis is equivalent to the previous hypothesis
stating that the difference in gas consumption at the observed mean temper-
ature is zero9. The results are exactly the same as in the previous test based
on the centering method. The estimated value for this difference is about
9This is because
E (Gas | Insul = After, Temp = Temp)− E (Gas | Insul = Before, Temp = Temp)
= β2 + β3Temp.
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1 DATA: FILE IS whiteside.dat;
2 VARIABLE: NAMES ARE INSUL TEMP GAS;
3 USEVARIABLES ARE TEMP GAS IAFTER INT;
4 DEFINE: IAFTER = 0; IF(INSUL EQ 2) THEN IAFTER = 1;
5 DEFINE: INT = IAFTER * TEMP;
6 ANALYSIS: TYPE = MEANSTRUCTURE;
7 MODEL:
8 GAS ON TEMP IAFTER INT;
9 IAFTER WITH TEMP;
10 INT WITH TEMP;
11 INT WITH IAFTER;
12 OUTPUT: TECH1; TECH3;
13 SAVEDATA:
14 RESULTS ARE whitesideunc.dat;
15 TECH3 IS whitesideunct3.dat; 
Listing 2.2: Mplus input for the Whiteside data.
−1.57 and the corresponding test statistic is about F = 319.5 (df = 1) which
is equivalent to the squared t-value −17.872 of the centering method.
The maximum likelihood method is applied in order to analyze the av-
erage effect of the insulation and to compare the results with the centering
method. TheMplus input is given in Listing 2.2 which estimates the following
regression model
E (Gas | Insul, Temp) = γo + γ1Temp+ γ2IAfter + γ3IAfterTemp. (2.51)
The results are given in Table 2.3. The estimated interaction effect is
identical to the previous results from the centering method. The correspond-
ing standard error and t-value are almost identical. Applying the concept of
the average treatment effect AE, the average effect (or the adjusted mean
difference) of the insulation on gas consumption (with regard to the outside
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Table 2.3
Summary of the Maximum Likelihood Analysis.
Estimate SE t
γ0 6.854
∗∗ 0.131 52.312
γ1 −0.393∗∗ 0.022 −18.147
γ2 −2.130∗∗ 0.174 −12.274
γ3 0.115
∗∗ 0.031 3.726
Temp 4.875∗∗ 0.364 13.388
AE −1.568∗∗ 0.094 -16.613
Note. This model is saturated.
temperature), is specified as
AE = γ2 + γ3 E (Temp). (2.52)
Using the parameter estimates from the ML method yields a value of
about −1.568. The corresponding standard error is about 0.094. It was com-
puted with the multivariate delta method (Cox & Hinkley, 1974; Stuard &
Ord, 1994; Wasserman, 2004) using the estimated variance-covariance ma-
trix of the model parameters from the ML estimation (requested in line 15
of Listing 2.2) and the gradient with respect to Equation 2.52. The corre-
sponding t-value is −16.613 which is significant at the .01 level. Hence, the
hypothesis of no average effect of the insulation can be rejected.
Comparing the results of the centering method with the ML method re-
veals that both methods provide similar results. The interaction and the
corresponding standard error are estimated almost identical in both meth-
ods. The only notable difference occurs by comparing the results for the
average effect from the ML estimation with the results for the β2 regression
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coefficient of the centering method. This comparison is of interest because
estimating and testing β2 based on the centering approach is sometimes used
and recommended in order to estimate and test average treatment effects
(here the average effect of the insulation). This was described in detail in
section 2.1.
Both methods provide exactly the same estimate (−1.568). However, they
differ with regard to the corresponding standard error. The standard error
of the maximum likelihood method is 0.094 whereas the standard error of
the centering method is 0.088. The standard error of the centering method
is about 7.1% smaller than the standard error of the maximum likelihood
method.
Based on the results of the previous discussions and the simulation study
this outcome is as expected. The centering approach provides an unbiased
estimate for β2 which can be interpreted as the estimated conditional effect
of the insulation at the mean of the outside temperature and is exactly the
same as the estimated average effect of the ML method. The standard error
of β2 of the centering approach can be used to test β2. However, because it is
about 7% smaller than the standard error of the average effect from the ML
estimation it should not be used to test the average effect of the insulation.
Note that the effect size of the interaction is considered small. The results
of the simulation study suggest that the difference in standard errors for the
two compared methods would have been even larger for an interaction with
a larger effect size.
The average effect estimated and tested by the ML method can be re-
garded as the adjusted mean difference of gas consumption before and after
the insulation was installed. The adjustment is done by statistically control-
ling for temperature differences between treatment conditions. The (unad-
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justed) mean difference of gas consumption after and before the insulation
is about −1.267 which is about 19% smaller than the mean adjusted for the
outside temperature. This result implies that the outside temperature is a
confounding variable and should be taken into account when evaluating the
effects of insulation on gas consumption. Under the assumption that there is
no other confounding variable (besides the outside temperature) the average
effect of the insulation (in other words the adjusted mean) can be interpreted
as the average causal effect of the insulation on gas consumption.
2.9 Summary
We have seen how to specify average treatment effects in regression mod-
els that include a treatment-covariate interaction with regard to an outcome
variable. It was shown that existing methods that center the covariate pro-
vide a method to estimate and test this average treatment effect under certain
conditions. It was also argued that the linear hypothesis test of the general
linear model also provides this test and is applicable to more cases. An ex-
ample was given for a regression model that involves higher order interaction
effects. It was also argued that centering as well as the linear hypothesis
yield inflated Type I errors when the covariate means are estimated from the
sample. Both methods treat the covariate means as fixed terms and not as
model parameters.
The outlined maximum likelihood procedure is an important contribution
to the methodology of the analysis of treatment effects, because in applied
settings it will often be the case that the mean E (Z) of the covariate will have
to be estimated from the sample. The simulation shows that the maximum
likelihood procedure provides unbiased estimates of the average treatment
CHAPTER 2. MANIFEST COVARIATES 50
effects as well as its standard error. The maximum likelihood procedure
should be given advantage over the multiple regression method especially if
medium or large interaction effects are present.
In summary the outlined procedure allows to incorporate covariates in
the analysis of treatment effects. It allows to study how the treatment effect
depends on covariates and also to estimate and test the average effect of a
treatment. The main limitation of the approach is that measurement errors
of the covariates are not accounted for. Many covariates in the social sciences
are however only measurable with a measurement error and it is well known
that such fallible covariates may bias the analysis of treatment effects (see,
e. g. Bollen, 1989; Cohen et al., 2003). The solution to this measurement
problem is to use structural equation modeling where the covariates are latent
variables. The following chapters introduce models that allow to estimate
and test average treatment effects if interaction effects between treatment
and latent covariates are present.
Chapter 3
Average Effects in Latent
Variable Modeling
3.1 A Latent Variable Model Involving In-
teraction between Treatment and Latent
Covariate
This section describes how the concept of average treatment effects can be ap-
plied for latent variable models that involve interactions between treatments
and latent covariates. The latent variable models considered include contin-
uous outcome variables. It is clear however, that methodology for categorical
or ordinal variables is needed in practice as well. If the outcome is simply
a continuous manifest variable, the procedures outlined here are applicable
simply by replacing the latent outcome with the manifest outcome.
Consider a study that is designed to investigate the effects of a treatment
on a latent outcome variable η measured by two observed variables Y1 and
Y2. The study is based on a treatment-control-group design. The two groups
51
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are represented by the treatment variable X with values j = 1, 2. The
study includes a continuous latent covariate ξ measured by two continuous
observed variables Z1 and Z2. The continuous latent covariate may represent
a latent pretest variable that is measured by two pretest measures before the
treatment is applied. This design is frequently used in the social science
research and has therefore been called workhorse design (see, e. g., Shadish
et al., 2002).
The interaction between the treatment and the latent covariate is ex-
pressed in terms of the regression equation
E (η |X, ξ) = α + β1IX=2 + β2ξ + β3IX=2ξ. (3.1)
The residual is defined in the usual way as ζ := η − E (η |X, ξ). IX=2 is an
indicator variable defined as
IX=2 :=
1 if X = 2,0 else, (3.2)
so that group one serves as the control group. Throughout the following
discussion, group one will be referred to as the control (or reference) group
and group two as the treatment group.
The latent covariate ξ is measured by two observed variables Z1 and Z2
with the following measurement model1
Z1 = νZ1 + λZ1ξ + Z1 ,
Z2 = νZ2 + λZ2ξ + Z2 ,
Cov(ξ, Z1) = Cov(ξ, Z2) = Cov(Z1 , Z2) = 0.
(3.3)
1A common way to identify this measurement model is to set νZ1 = 0 and λZ1 = 1.
Identification issues of the measurement models are discussed later.
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Figure 3.1: Latent variable model involving an interaction between a
dichotomous treatment variable and a continuous latent covariate.
The two observed variables Y1 and Y2 measure the latent outcome η with the
following measurement model:
Y1 = νY1 + λY1η + Y1 ,
Y2 = νY2 + λY2η + Y2 ,
Cov(η, Y1) = Cov(η, Y2) = Cov(Y1 , Y2) = 0.
(3.4)
Both measurement models represent the model of τ -congeneric variables
(for a more detailed description of these measurement models see Steyer,
2001 or Steyer & Eid, 2001). The measurement residuals Z1 , Z2 , Y1 , and
Y2 are assumed to be uncorrelated.
Except for the interaction of the latent covariate with the treatment,
this is a standard SEM model. It is represented by the path diagram in
Figure 3.1. The arrow labeled with β3 which begins at ξ and IX=2 and points
to η describes the interaction. Another way to represent the interaction is
given in Figure 3.2. The arrow with the dotted line emphasizes that the
effect of IX=2 depends on ξ. The corresponding label of the arrow gives the
effect function instead of the regression coefficient of the interaction.
This latent variable model may, for example, describe the interaction be-
tween a treatment and a pretest with regard to post-test, where both the
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Figure 3.2: An alternative way to represent a latent variable model
involving an interaction between a dichotomous treatment variable
and a continuous latent covariate.
pretest and the post-test are variables that are measured with a measure-
ment error. The regression in Equation 3.1 is similar to an ordinary multiple
regression with an interaction term. Most readers will be familiar with this
multiple regression approach involving manifest variables, often termed mod-
erated multiple regression (Aiken & West, 1991; Jaccard et al., 1990; Judd &
McClelland, 1989; Saunders, 1956). Like in the manifest regression the inter-
pretation of Equation 3.1 is as follows. With an interaction effect present, β1,
the first-order effect of the treatment, should in general not be interpreted
as the main effect or the average effect of the treatment.
To establish the meaning of β1 consider the regressions of η on ξ for each
group
EX=1(η | ξ) = α + β2ξ
EX=2(η | ξ) = α + β1 + β2ξ + β3ξ.
(3.5)
The difference of these two regressions for a given value of ξ is called condi-
tional effect of the treatment. The function
g2−1 := EX=2(η | ξ)− EX=1(η | ξ) = β1 + β3ξ (3.6)
is called effect function. It is apparent that β1 represents the conditional effect
CHAPTER 3. AVERAGE EFFECTS IN SEM 55
of the treatment at the value 0 of the latent covariate. Thus, the meaning
of the latent covariate value 0 must be considered in order to interpret β1.
Hence, scaling ξ so that E (ξ) = 0 ensures that the interpretation of β1, the
first order-effect of the treatment, occurs at a meaningful value of the latent
covariate.
To return to the concept of the average treatment effect, the question is,
if β1 can be interpreted as the average (or the main) effect of the treatment
if E (ξ) = 0. To answer this question, a definition of the average effect of
the treatment is required. Consider g2−1(ξ), the effect function (given in
Equation 3.6), that maps each covariate value to the conditional treatment
effect. It is clear that the expected treatment effect depends (linearly) on the
latent covariate. The latent covariate is called a moderator (see, e. g., Baron
& Kenny, 1986).
For the given example, AE 2−1, the average effect of treatment two vs.
control is specified as the average of the conditional effect function
AE 2−1 = E
(
g2−1(ξ)
)
= E (β1 + β3ξ) = β1 + β3 E (ξ). (3.7)
The function g2−1 maps every value of ξ to the conditional treatment ef-
fect. This function is as a random variable. Hence, the average effect of the
treatment is defined as the average (or the expected value) of this random
variable. If no interaction is present (i. e. β3 = 0), then the conditional
treatment effects are the same across all values of ξ. Consequently the aver-
age treatment is equal to β1, the constant value of the conditional treatment
effects.
If an interaction is present however, Equation 3.7 shows that the average
treatment effect is a (non-linear) function of the three parameters β1, β3, and
E (ξ). It is obvious that scaling ξ so that E (ξ) = 0 ensures that β1, the first
order effect of the treatment, is equal to the average treatment effect. This
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will be important throughout the following chapters.
3.2 Generalizations
The example of the last section included only one (continuous) covariate and
only two treatments (or treatment groups). The concept may be generalized
to more than two treatments and to possibly multiple latent covariates.
Let there be J treatment groups. The treatment variable X may take on
the value X = 1 for control, and X = 2, . . . , X = J for the treatment groups.
The following J − 1 dummy codes may be used to identify each treatment:
IX=2, . . . , IX=J indicate with 1 and 0 whether or not the observational unit
is assigned to treatment j, with j = 2, . . . , J .
The regression equation of the outcome variable Y regressed on the treat-
ment and the latent covariates can generally be written as
E (η |X, ξ) = g1(ξ) + g2−1(ξ) · IX=2 + · · ·+ gJ−1(ξ) · IX=J , (3.8)
where ξ represents a univariate or multivariate latent covariate. Consequently
there are J − 1 average effects, which are defined as:
Definition 2. The average effect AE j−1 of treatment j (compared to the
control group X = 1) with regard to the covariate ξ is defined as the average
of the effect function gj−1(ξ),
AE j−1 = E
(
gj−1(ξ)
)
, (3.9)
with j = 2, . . . , J.
Note again that the average effect is defined with regard to the covariate ξ.
For a different covariate the average treatment effect might differ. However,
if the regression is causally unbiased (e. g. given a randomized design),
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then it can be shown that the average treatment effect is the same for all
(combinations) of possible covariates (see Steyer et al., 2007, for a detailed
discussion of this topic on causality).
In the following, I describe methods to estimate and to test the average
treatment effect for the two-group example. Two cases are treated sepa-
rately. First, chapter 3.3 treats the case where randomization is successfully
implemented in the study. Standard multiple group analysis is applicable
by imposing certain constraints on the model parameters. Second, chap-
ter 4 describes methods on how to analyze average treatment effects for
non-experimental designs, in other words designs, where randomization is
not (successfully) implemented.
3.3 Average Treatment Effects in Random-
ized Studies
3.3.1 A General Latent Variable Framework
The model represented by Equations 3.1 - 3.4, includes a (linear) interaction
between a dichotomous observed variable IX=2 and a continuous latent vari-
able ξ. Models including this type of interaction are typically analyzed with
the following general latent variable framework (cf. Bollen, 1989; Jo¨reskog
& So¨rbom, 1979; So¨rbom, 1978). For treatment (or in general population)
j, consider a p-dimensional observed variable vector y(j) related to an m-
dimensional latent variable vector η(j) through a factor-analytic measure-
ment model
y(j) = ν(j) +Λ(j)η(j) + (j), (3.10)
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where ν(j) is a vector of measurement intercepts, Λ(j) is a p×m-dimensional
matrix of measurement slopes (factor loadings), and (j) is a p-dimensional
vector of measurement residuals. The variance-covariance matrix of the mea-
surement residuals is Var((j)) = Θ(j).
The latent variables have the structural relations
η(j) = α(j) +B(j)η(j) + ζ(j), (3.11)
where α(j) is an m-dimensional vector of structural intercepts (for endoge-
nous latent variables) or means (for exogenous latent variables), B(j) is an
m-dimensional matrix of structural slopes, and ζ(j) is and m-dimensional
vector of structural residuals. Var(ζ)(j) = Ψ(j) is a residual (for endogenous
latent variables) or latent variable covariance matrix (for exogenous latent
variables).
Under regular assumptions on the residuals, we have the mean and the
covariance structure
E
(
y(j)
)
= µ(j) = ν(j) +Λ(j)
(
I −B(j)
)−1
α(j) (3.12)
and
Cov
(
y(j)
)
= Σ(j) =
= Λ(j)
(
I −B(j)
)−1
Ψ(j)
(
I −B(j)
)−1′
Λ(j)
′
+Θ(j). (3.13)
This is the standard multiple-group structural equation modeling frame-
work. With the customary assumption of i.i.d. sampling from each of the J
populations, a simultaneous, multiple-group (multiple-population) analysis
is commonly achieved by minimizing the fitting function F
F =
J∑
j=1
(
N (j)
[
ln |Σ(j)|+ tr
(
Σ(j)
−1
T (j)
)
− ln|S(j)| − p
])
/(N − 1), (3.14)
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where N is the total sample size and
T (j) = S(j) +
(
y¯(j) − µ(j)) (y¯(j) − µ(j))′ , (3.15)
which gives maximum-likelihood estimation under multivariate normality for
y(j) (see, e. g., Jo¨reskog & So¨rbom, 1979; So¨rbom, 1982). At the optimal
value of F , (N − 1)F has asymptotically a chi-squared distribution.
3.4 A Standard Multi-group Model
The (single-group) model represented by Equations 3.1 - 3.4 may be fitted
into the general latent modeling framework (So¨rbom, 1978). For j = 1, 2
consider the structural part
η(j) = α(j) + β(j)ξ(j) + ζ(j), (3.16)
the measurement models2
Y
(j)
1 = ν
(j)
Y1
+ λ
(j)
Y1
η(j) + 
(j)
Y1
,
Y
(j)
2 = ν
(j)
Y2
+ λ
(j)
Y2
η(j) + 
(j)
Y2
,
Z
(j)
1 = ν
(j)
Z1
+ λ
(j)
Z1
ξ(j) + 
(j)
Z1
,
Z
(j)
2 = ν
(j)
Z2
+ λ
(j)
Z2
ξ(j) + 
(j)
Z2
,
(3.17)
and the additional assumptions
Cov (j)(ξ, Z1) = Cov
(j)(ξ, Z2) = Cov
(j)(Z2 , Z2) = 0,
Cov (j)(η, Y1) = Cov
(j)(η, Y2) = Cov
(j)(Y2 , Y2) = 0,
Cov (j)(Z1 , Y1) = Cov
(j)(Z1 , Y2) = Cov
(j)(Z2 , Y1) =
= Cov (j)(Z2 , Y2) = 0.
(3.18)
2The measurement models may be identified for example by setting ν(1)Y1 = ν
(1)
Z1
= 0
and λ(1)Y1 = λ
(1)
Z1
= 1. The identification of the measurement models is described later.
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Let y in Equation 3.10 contain all observed variables Y1, Y2, Z1, and Z2
and η contain the two latent variable η and ξ. The parameters of Equa-
tions 3.10 and 3.11 are as follows: ν(j) contains the measurement intercepts
ν
(j)
Y1
, ν
(j)
Y2
, ν
(j)
Z1
, and ν
(j)
Z2
of each group; Λ(j) contains 0s and the measure-
ment slopes λ
(j)
Y1
, λ
(j)
Y2
, λ
(j)
Z1
, and λ
(j)
Z2
; Θ(j) contains the variance-covariance
matrix of the measurement residuals 
(j)
Y1
, 
(j)
Y2
, 
(j)
Z1
, and 
(j)
Z2
; α contains α(j)
the structural intercept of each group and E (j)(ξ), the mean of the covariate
of each group; B contains 0s and the structural slopes β(j); finally Ψ con-
tains Var (j)(ζ) the variance of the structural residual as well as Var (j)(ξ) the
variance of the latent covariate of each group.
This two-group model may be described in path diagram form as shown
in Figure 3.3. It is straightforward how to generalize this two-group model
to multiple groups. Although the single-group model (Equations 3.1 - 3.4)
may be analyzed with the multi-group model in the outlined way, the two
models are not identical. The multi-group model is more general in that
it enables population (or group) differences with regard to the variances of
the structural residual. These differences are not offered by the single-group
model.
In the following, it is shown how the multi-group approach can be used
to analyze treatment effects for randomized studies if interactions between
treatment and latent covariates are present. For the sake of simplicity and
continuity the examples are done with Mplus.
Consider an intervention study where individuals are measured before
being randomized into a treatment or a control group and then measured
thereafter. In line with Jo¨reskog and So¨rbom (1979), this may be viewed
as data from two different populations. The control group population rep-
resents the normative set of outcomes that would have been observed also
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Figure 3.3: A multi-group model to analyze interaction between
treatment and a latent covariate.
in the treatment group had the individuals not been chosen for treatment.
The effect of treatment is assessed by comparing the outcomes in the treat-
ment population with those in the control population. Treatment effects are
assessed by comparing the regressions of η on ξ for each group:
EX=1(η | ξ) = α(1) + β(1)ξ
EX=2(η | ξ) = α(2) + β(2)ξ.
(3.19)
The measurement models of the single-group approach and the multi-
group approach are equivalent if the parameters of the multi-group approach
are set invariant across the groups. Because it simplifies the identification
of the multi-group models considerably and because the focus here is on
the treatment effect rather than measurement equivalence, the measurement
models of the groups are treated invariant throughout the discussion of the
multi-group approach.
The structural equations of the multi-group model are equivalent to the
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structural equation of the single-group model (see Equation 3.5), if
α(1) = α β(1) = β2
α(2) = α + β1 β
(2) = β2 + β3.
(3.20)
The interpretation of the parameters is therefore identical to the single-
group model. An interaction effect is present if β(2) − β(1) 6= 0. Given an
interaction, α(2)−α(2) can be interpreted as the treatment effect at the value
0 of ξ but in general not as the average treatment effect.
The effect function for the multi-group model is computed by the differ-
ence of the group specific structural regressions (see Equation 3.19)
g2−1(ξ) = EX=2(η | ξ)− EX=1(η | ξ)
= α(2) − α(1) + (β(2) − β(1)) ξ. (3.21)
The average treatment effect is specified as the mean of the the effect
function
AE 2−1 = E [g2−1(ξ)] = α(2) − α(1) +
(
β(2) − β(1))E (ξ). (3.22)
Usually hypotheses in SEM are about (single) parameters or linear com-
binations of these. For example, the hypothesis assuming that no interaction
effect is present can be written as β(2) − β(1) = 0 (see, e. g., Jaccard & Wan,
1996). Equation 3.22 however shows that the average effect is a function
of the two structural intercepts and the two structural slopes with the two
structural slopes multiplied by the mean of the latent covariate. Whereas
α(1), α(2), β(1), and β(2) are parameters of the multi-group model, E (ξ), the
(grand-) mean of the latent covariate, is not a parameter of the multi-group
model. Without further adjustment this would make the multi-group model
not feasible to analyze average treatment effects. I describe solutions that
allow to apply the multi-group approach to the analysis of average effects.
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The following section treats randomized designs. Chapter 4 will then focus
on non-randomized designs and the comparison between multi-group and
single-group approach.
Based on a randomized design it is possible to use the multi-group analysis
to analyze average treatment effects. As a consequence of randomization the
treatment assignment is independent from ξ. Hence the expected values of
the latent covariate are equal across the two populations. It is therefore
justified to set these means equal and use the corresponding estimate as an
estimate for the grand mean of the latent covariate. It is also possible to set
the variance of the latent covariate equivalent across the groups. This will
however not be considered here because it is irrelevant for analyzing average
treatment effects.
3.4.1 Scaling the Latent Variables
Given randomization, the key principle of the multi-group approach in order
to analyze average treatment effects is to pose equality constraints on the
group means of the latent covariate
E (ξ |X=1) = E (ξ |X=2). (3.23)
For the sake of simplicity, the parameters of the measurement models of both
latent variables are restricted to be equal across groups. For k = 1, 2 we have
ν
(1)
Zk
= ν
(2)
Zk
λ
(1)
Zk
= λ
(2)
Zk
(3.24)
ν
(1)
Yk
= ν
(2)
Yk
λ
(1)
Yk
= λ
(2)
Yk
. (3.25)
The latent variables are typically scaled by setting (at least) one measure-
ment slope of each measurement model to one, for example λ
(1)
Y1
= λ
(1)
Z1
= 1.
I will describe two ways to complete the scaling of the latent variables and
the consequences for the analysis of the average effect.
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Centering the Latent Covariate
One way to complete the scaling of the latent covariate ξ is to set the mean
of the latent covariate in group one to zero
E (ξ |X=1) = 0. (3.26)
Because the means of ξ are set equal across the groups (Equation 3.23), the
overall mean of ξ is zero
E (ξ) = 0. (3.27)
The scaling of the latent outcome variable may be completed by fixing the
structural intercept in group one to zero
α(1) = 0. (3.28)
The main advantage of this scaling is that the identification of the average
effect (see Equation 3.22) is reduced to the single parameter
AE 2−1 = α(2), (3.29)
the intercept of the latent outcome variable in the second group. Hence,
the average treatment effect can be estimated and tested by estimating and
testing the single parameter α(2).
Listing A.3 on page 143 gives an example for a Mplus input. The cor-
responding Mplus output includes information about the overall model fit
as well as estimates and tests for each parameter of the model, including
standard errors and t-values. The parameters of special interest here are of
course β(1) and β(2), the structural slopes the two groups. The difference
between these two parameters is an estimate for the interaction effect. The
interaction will be further discussed below.
CHAPTER 3. AVERAGE EFFECTS IN SEM 65
If no interaction effect is present, the effect of the treatment is constant
across all values of the latent covariate and equal to α(2). It is trivial that
the average treatment effect is equal to this constant measure.
The outline of the last paragraphs however has shown that the average
treatment effect is also equal to α(2), if an interaction effect is present. Be-
sides the estimate and the standard error Mplus also prints the estimate
divided by the standard error, a test statistic that is approximately normally
distributed (z-score) in large samples, which may be used to test the null
hypothesis stating that no average treatment effect is present. Testing the
average treatment effect against values different than zero is also possible.
The difference between the estimate of α(2) and the value that it is tested
against (assuming this value is the true population parameter) divided by the
estimated standard error is a test statistic which is (approximately) normally
distributed (z-score) in large samples.
Testing the interaction may be done by a chi-square difference test be-
tween the model specified in Listing A.3 on page 143 and the identical model
with an additional equality constraint on the two structural slopes (Jaccard
& Wan, 1996). Programs like Mplus (Version 4) and LISREL also offer the
option to directly test the interaction, without the need of a second restricted
model. These programs offer to specify an additional parameter that may
be tested against a certain value. Listing A.4 on page 143 gives the corre-
sponding Mplus input. Lines 1 to 8 are identical to the ones in Listing A.3.
Lines 9 to 13 implement the additional test for the interaction.
The output of Listing A.4 is identical to the output of Listing A.3 except
for the additional parameter specifying the interaction. The same infor-
mation is provided for the interaction effect as it is provided for all model
parameters, including the estimate and the standard error of the interaction
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effect. And the estimate divided by the standard error is again a test statis-
tic that is approximately normally distributed (z-score) in large samples.
Testing the interaction effect against values different than zero is again done
by subtracting the hypothetical true population value from the estimated
interaction effect and dividing it by the standard error.
Using this method it is possible to simultaneously test the interaction
effect and the average treatment effect. In this way the analysis reveals if
and how the effect of the treatment on the outcome depends on the latent
covariate. Given this interaction model Jaccard and Wan (1996) suggested
to ignore the latent covariate in order to test the average effect. The authors
though it would be impossible to analyse the average treatment effect (also
referred to as main effect) with a model that includes the interaction. The
outlined method shows however that it is possible to analyze the average
treatment effect without ignoring the interaction with the latent covariate.
An Alternative Scaling Method
There are alternative ways to scale the latent variables. Instead of setting the
mean of the latent covariate and the structural intercept of the latent outcome
in group one to zero they may be set free and one measurement intercept of
each measurement model may be set to zero, for example ν
(1)
Y1
= ν
(1)
Z1
= 0.
Note that the group means of the latent covariate are still set equal across
groups. Given this scaling, the average treatment effect can be estimated
with the estimates of the involved parameters according to Equation 3.22.
Testing the average treatment effect requires the specification of an additional
parameter. The corresponding Mplus input given in Listing A.5 on page 144.
Listing A.5 is contains more statements than Listing A.3 because the
alternative scaling method requires more parameter specifications that differ
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from the default settings. The measurement intercepts are set free and equal
across groups per default3. Line 7 and 8 of Listing A.5 specify the first
measurement intercepts for both measurement models to zero in both groups.
The measurement slopes are set equal across groups per default. The first
measurement slopes of each measurement model, λ
(1)
Y1
and λ
(1)
Z1
, are set to
one per default. Hence, both inputs do not need further statements in order
to specify tau-congeneric measurement models. The measurement errors of
the observed variables are set equal across groups and are assumed to be
uncorrelated with each other.
The group means of ξ in both inputs are set equal across groups. In
Listing A.3 the group means of ξ are set to zero in line 7 with [XI@0];
whereas in Listing A.5 they are constrained to be equal by placing the same
name in parentheses following the parameter specification in each group (line
10 and 13). The structural intercepts and slopes in Listing A.5 are set free
and are named by placing a name in parentheses after the parameter in order
to use them for the additional (or new) parameter that specifies the average
effect.
It is also important to note that the multi-group approach is more general
than the single-group model given in Equations 3.16 to 3.17 because it allows
several parameters to differ between the groups, that are implicitly treated
constant in the single-group model. The variance of the structural residual,
for example, may be different in the control group than in the treatment
group.
Both inputs (i. e. models) yield the same model fit and the same results
for the average treatment effect. As mentioned before, the test of the in-
teraction effect may be included in the analysis by specifying an additional
3Hence, no statements are required in Listing A.3
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(or new) parameter using the difference between the two structural slopes of
the two groups. Testing the interaction may be included in the alternative
scaling version by adding an additional parameter in the same way it is done
in Listing A.4.
We have seen that the general latent modeling framework can be used to
examine average (or main) treatment effects and interaction effects simulta-
neously. The key principle was to constrain the means of the latent covariate
to be equal across groups, which is feasible in randomized designs. Tradition-
ally, such an analysis was considered not possible (see, e. g., Jaccard & Wan,
1996, p. 41) and interaction effects were examined separately from main (or
average) effects. In a randomized design it is possible to perform the test
of the average treatment effect separately simply by ignoring the latent co-
variate and comparing the group means of the (latent or observed) outcome
variables. Ignoring the latent covariate however may lead to an increase in
residual variance and to a considerable loss in power. This will be discussed
in the next section.
3.5 Power for Randomized Designs
For randomized designs, it is possible to analyze the average effect of the
treatment simply by comparing the outcome means of each group. Ignoring
the latent covariate in the analysis yields an causally unbiased estimation of
the average treatment effect (see Steyer et al., 2007, for details). However,
including the latent covariate in the analysis has two advantages. First, it
allows to simultaneously analyze the average effect of the treatment and the
interaction with the latent covariate. Second, the latent variable may reduce
the variance of the structural residual, yielding more power to detect an
average treatment effect.
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It is expensive and time-consuming to carry out interventional studies
and particularly so with a large number of participants. It is therefore im-
portant to know the minimum number of participants that can be used to
answer the research questions. For the design of an interventional study, it is
critical to estimate power to detect certain effects, such as average effects and
interaction effects. The following section of this thesis aims to present some
relevant power results for randomized interventional studies. The power es-
timation of the outlined general latent variable framework with regard to
average treatment effects is based on a method developed by Satorra and
Saris (1985).
The estimation of power to detect misspecified latent variable models has
been discussed in Satorra and Saris (1985) and Saris and Satorra (1993); see
also Saris and Stronkhorst (1984). In principle, power can be estimated for
any model by carrying out a Monte Carlo study that records the proportion
of replications in which the incorrect model is rejected. Satorra and Saris
proposed a method that gives a tremendous simplification over such a brute
force approach. A key technique is based on the likelihood-ratio chi-square
test for maximum-likelihood estimation of mean and covariance structure
models such as the one given in Equations 3.12 and 3.13. This technique is
applied in the following to estimate power to detect intervention effects in the
two-group latent variable model discussed above. The Satorra-Saris approach
is particularly suitable for the intervention setting given that power estimates
are desired for very specific model misspecifications concerning absence of
treatment effects.
Under multivariate normality for y(j), (N − 1)Fmin, where Fmin is the
optimal value in Equation 3.14, is distributed asymptotically as a chi-square
variable when the model in Equations 3.12 and 3.13 is correct. Satorra and
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Saris (1985) showed that when the model is incorrect but not highly misspec-
ified, (N − 1)Fmin is asymptotically distributed as a non-central chi-square
variable with a certain non-centrality parameter, which can be approximated
by a two-step procedure. This procedure involves two models, one more
general that is assumed correctly specified and one more restrictive that is
misspecified.
In the given intervention setting, we are interested in the power to detect
intervention effects and the more restrictive model sets the corresponding
parameter(s) to zero. As a first step, the more general two-group latent
variable model is estimated including the treatment effect(s). In a second
step, the estimated mean vectors and covariance matrices from Step 1 are
used in place of the corresponding sample statistics and analyzed by the
more restrictive model that sets the treatment effect parameter(s) to zero.
The value of (N − 1)Fmin in this second step represents an approximation to
the non-centrality parameter. Once this parameter has been obtained, the
power can be computed from tables for non-central chi-square distributions
as a function of the degrees of freedom and the α-level of the test (see, e. g.,
Saris & Stronkhorst, 1984). Listing B.1 on page 148 gives a short R program
that computes the power in this way. The degrees of freedom refer to the
number of treatment effect parameters.
Saris and Satorra (1993) point to simulation studies that indicate that
this procedure for estimating power can be sufficiently accurate for practical
purposes at small sample sizes. To verify the accuracy for the presented
two-group latent variable model, several simulation studies were carried out.
The proportion of the replications for which the t value of the treatment
effect (parameter) exceeded its 5% critical value was recorded. This t value
refers to the incorrect hypothesis of zero treatment effect (parameter). The
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studies focused on power values close to .8, varying the sample size and
several other parameters as well as the method to estimate and test average
treatment effects. The estimated power values of the Satorra-Saris method
were compared to the simulation studies.
In the following sections, the Satorra-Saris method for estimating power
will be used to compute power curves as a function of sample size for a
variety of parameter combinations for the latent two-group model shown in
Figure 3.3. Parameter values were chosen to represent various treatment
effect sizes. These values generate the mean vectors on covariance matrices
that are used in the second step of the power method. The power curves will
be shown for different cases of the latent two-group model. Many different
situations are in principle of interest: We may have an experimental study
with individuals randomized into treatment and control groups, or the study
may be non-experimental with pre-existing differences measured by latent
covariates; there may be interactions between the treatment and the latent
covariates, or not. This chapter considers experimental (randomized) designs
with latent covariates.
The calculation of power curves calls for a consideration of effect size
(Cohen, 1988). In a traditional two-group t-test setting, effect size is typically
defined as the treatment and control group difference in outcome means,
divided by a standard deviation based on the pooled outcome variance. A
small effect size is typically taken to be .2, a medium effect size .5, an a large
effect size .8 (Cohen, 1988).
In the latent variable model setting, the definition of effect size is not
as straightforward. First, although Cohen-type definitions concern manifest
variables, treatment effects in the discussed models can also be expressed in
terms of latent variables. For example, in the Figure 3.3 model, the treatment
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effect may be expressed in terms of the mean difference of the observed or
the latent outcome, as well as the average effect of the treatment as given in
Equation 3.22 (see also Equation 3.7).
Second, if reporting Cohen-like effect sizes for manifest variables, the stan-
dard deviation could be based on the control group rather than pooling over
the treatment and control groups. The control group provides the normative
value, whereas the treatment group variance in part reflects the treatment
effect. In this thesis, I report effect sizes in several of these metrics.
3.5.1 Analysis of Examples
The power calculations to be illustrated below raise the issue of how small
the sample size can be for trustworthy analysis results given the dependence
on asymptotic theory. Here, it should be noted that considerations of power
may suggest sample sizes that are smaller than what can be recommended for
obtaining good estimates of parameters and standard errors. For example,
the simple latent variable model in Figure 3.3 has 13 parameters in the
control group (given tau-congeneric measurement models and the scaling
described in section 3.4.1). A conventional requirement in the latent variable
literature is 5 to 10 observations per parameter (see, e. g., Bentler & Chou,
1988). Using this rule of thumb would lead to a minimum of 65 preferably
130 control group observations. With a balanced design, a total of 130 to
260 control and treatment group observations may therefore be desired for
this particular model. This total sample size requirement may exceed the
number required for a power of at least .8 and this should be kept in mind
when studying the power figures below.
For the power calculations of the latent two-group model given in Fig-
ure 3.3 (Equations 3.16 to 3.17), the following parameter values are chosen.
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Data are generated using a normally distributed ξ with mean of zero
E (ξ) = 0 (3.30)
and variance of one (for both groups)
Var(ξ) = 1. (3.31)
Observations are randomly assigned to the two groups with fixed group sizes.
The parameters of the measurement models of the two latent variables η
and ξ are set equal across the groups. λ
(j)
Zk
, the slopes (or factor loadings)
for the measurement model of ξ, are set to one. The corresponding residual
variances of the factor indicators are .5 with zero correlation between the
two residuals Z1 and Z2 . The corresponding measurement intercepts νZk
are zero. These parameters are chosen to give indicator reliabilities of about
.66 using the following formula4
Rel(Zk) =
λ
(j)
Zk
2
Var (j)(ξ)
λ
(j)
Zk
2
Var (j)(ξ) + Var (j)(Zk)
, (3.32)
for k = 1, 2 and j = 1, 2.
The parameters of the measurement model of η are set to the same values
as the measurement model of ξ yielding similar reliabilities of Yk. However,
the reliability of the factor indicators for η varies to some extend with the
variance of η, which depends on the parameters of the structural equations.
The parameters of the measurement models are the same throughout the
following power calculations and are summarized in the following equations
ν
(j)
Yk
= ν
(j)
Zk
= 0, λ
(j)
Yk
= λ
(j)
Zk
= 1, and (3.33)
Var (j)(Yk) = Var
(j)(Zk) = 0.5, where k = 1, 2. (3.34)
4This formula is derived from Bollen (2002) when there are no correlated errors of
measurement.
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The measurement residuals are uncorrelated with each other and uncorre-
lated with the latent variables.
The structural intercept given the control group is set to
α(1) = 0.2. (3.35)
Given E (ξ) = 0 and α(1) = 0.2, the average effect is computed by the differ-
ence between the two structural intercepts (see Equation 3.22)
AE = α(2) − 0.2. (3.36)
The structural intercept in group two varies between the values .2, .4, .7, and
1 in order to vary the average treatment effect. The corresponding average
treatment effect values are 0, .2, .5, and .8.
The group-specific variances of the structural residual, are held equal
across the groups: Var (j)(ζ) = Var(ζ). The structural residual variance is
varied in order to vary the proportion of the variance of η that is explained
by ξ. Var(ζ) varies between the values .1, .3, .5, .7, .9, and 1. The structural
slope in the first group is set depending on Var(ζ) by the formula
β(1) =
√
1− Var(ζ)
Var(ξ)
. (3.37)
With Var(ξ) = 1, Var(η) the variance of the latent outcome in the first group
is always one (see Equation C.4 on page 151). As a consequence the correla-
tion between ξ and η in the first group is equal to β(1) (see Equation C.5 on
page 151). The corresponding coefficient of determination for group one is
R
2 (1)
η | ξ =
Var(EX=1(η | ξ))
Var (1)(η)
= β(1)
2
. (3.38)
Table 3.1 on the following page gives a summary about the parameters
that vary with Var(ζ). The structural slope of the control group is computed
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Table 3.1
The Values for Var(ζ) and the Corresponding Values
of β(1) (see Equation 3.37) and R
2 (1)
η | ξ .
Var(ζ) 1 .9 .7 .5 .3 .1
β(1) 0
√
.1
√
.3
√
.5
√
.7
√
.9
R
2 (1)
η | ξ 0 .1 .3 .5 .7 .9
so that the variance of η in the control group is always one. This is done
because the variance of η in the control group serves as a norm used to
compute the measures of effect size for the average treatment effect as well
as the interaction effect.
Following Cohen’s (1988) classification, the average treatment effect val-
ues of 0, .2, .5 and .8 are referred to as a small, medium and large effect,
respectively. The interaction effects are varied by adding 0, .2, .5, or .8 to
β(1). The non-zero interaction effects are categorized as small, medium and
large correspondingly. The last examples of the power analyzes for random-
ized designs will focus on unbalanced designs and vary the proportion of
observations in the treatment group.
3.5.2 Interaction Effects
An aspect of the latent multi-group model is to estimate and test interac-
tion effects between treatment and latent covariates. The following section
describes how to analyze the power of the latent multi-group model to de-
tect interaction effects with different effect sizes. Power values are obtained
using the Satorra-Saris method described in section 3.5. As a first step, the
mean vectors and covariance matrices for each group are computed using
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Equations 3.12 to 3.13 on page 58 for the latent two group model with the
population parameters as specified above. The resulting mean vectors and
covariance matrices are written in a file (pop.dat) so that Mplus can read
them.
In a second step, the more general two-group latent variable model (in-
cluding the interaction) as well a the restricted model (without the interac-
tion) are “estimated”. The Mplus input for the more general model is given
in Listing A.6 on page 144. The Mplus input of the model restricted for no
interaction effect is obtained from the same input by commenting out line
11 and uncommenting line 12. The number of observations for each group is
set arbitrary to 1000, a value large enough for sufficient precision.
The third step is to compute the difference between the chi-square value of
the restricted model and the chi-square value of the unrestricted model. This
chi-square difference is then used in the R program to compute power values
(see Listing B.1). The power values for other sample sizes are calculated by
multiplying the chi-square difference by the ratio of the new sample size to
the original sample size (here 2000). This value represents an approximation
to the non-centrality parameter. The restriction for the interaction effect has
df = 1. An alpha level of 0.05 is used throughout this discussion.
Figure 3.4 gives power curves for the two-group latent variable model to
detect interaction effects with different effect sizes. The sample sizes range
from 50 to 1,000. Here, sample size refers to the total number of observations
that are assigned equally to control and treatment resembling a balanced
design.
The variance of the structural residual is fixed to Var(ζ) = 1 and the
corresponding value of β(1) to 0. In other words, the latent covariate does
not explain any variance in the control group (i. e. R
2 (1)
η | ξ = 0; see Table 3.1).
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Note again that the variance of η in the control group, Var (1)(ξ) = 1 is used
as a norm for the effect size measures of the interaction effect. Three values
for the interaction effect are considered .2, .5, and .8 with the corresponding
effect size small, medium and large.
The structural intercept is set to α(j) = 0.2 in both groups, resulting in
an average treatment effect of zero. It is important to note that the power
analysis of the interaction effect is not limited to the case of no average treat-
ment effect. This means that it is possible to assess the power of detecting
an interaction while allowing for an average treatment effect.
Figure 3.4 shows that a large total sample size of over 1,000 is needed
to achieve a power of .8 for a small interaction effect size. The sample sizes
needed to achieve the same power is considerably smaller for medium or large
interaction effects (about 200 and less than 100 respectively). This finding
is in line with the case of interactions in multiple regression (Aiken & West,
1991) and longitudinal modeling (B. O. Muthe´n & Curran, 1997).
A second set of power curves (with regard to the interaction effect) is
computed for the case that ξ explains 90% of the variance of η in the con-
trol group. The structural residual variance is set to Var(ζ) = 0.1 and the
corresponding structural slope in group one to β(1) =
√
0.1. This yields a
coefficient of determination of R
2 (1)
η | ξ = 0.9 (see Table 3.1). All other param-
eters are as in the previous example. Figure 3.5 shows power curves of the
latent two group model to detect an interaction with a small, medium, and
large effect size.
Given a much smaller variance of the structural residual it is obvious
that less observations are needed to achieve the same power as before in
Figure 3.4. A power of .8 is achieved with about 780 observations given a
small interaction, with about 150 observations given a medium interaction
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Figure 3.4: Power to detect a small, medium, or large interaction
effect as a function of total sample size for a balanced randomized
design, no average treatment effect, and R
2 (1)
η | ξ = 0.
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Figure 3.5: Power to detect a small, medium, or large interaction
effect as a function of total sample size for a balanced randomized
design, no average treatment effect, and R
2 (1)
η | ξ = 0.9.
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and with less than 100 observations given a large interaction effect. It is still
remarkable how many observations are required to detect small interactions,
even if the structural residual variance is small.
To verify the Satorra-Saris method for the given model a Monte Carlo
Study with a balanced and randomized design is conducted with a sample
size of 800, R
2 (1)
η | ξ = .9, no average treatment effect and a small interaction
effect. The mean of 1, 000 estimates for the interaction was .2 which is exactly
the expected value, the standard deviation of these estimates was .08. The
observed power of .709 was obtained by counting the number of significant
interactions (709 out of 1000) at an alpha level of .05. This number is close
to the value .703 computed with the Satorra-Saris method. The Mplus input
for this Monte Carlo simulation is given in Listing A.8 on page 145.
3.5.3 Average Treatment Effects
The main focus of the power analysis is now on the average treatment ef-
fect. The following paragraphs discuss the power of the latent multi-group
approach to detect an average treatment effect for randomized studies. As
mentioned earlier, an unbiased estimate for the average treatment effect may
be obtained simply by the mean difference in the (latent or observed) out-
come variables. Figure 3.6 shows the pathdiagram of a latent multi-group
model without the latent covariate.
This latent multi-group model can be identified in a similar way as the la-
tent multi-group model that includes the latent covariate, using tau-congeneric
measurement models and setting the mean of the latent outcome in one group
to zero. However, constraining this model so that the average treatment ef-
fect is set to zero α(2) − α(1) = 0, yields a non-identified model. Given the
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Figure 3.6: A multi-group model without the latent covariate.
tau-congeneric measurement model, the parameter λ
(1)
Y2
is identified with
λ
(1)
Y2
=
E (Y2)
(1) − E (Y2)(2)
α(1) − α(2) . (3.39)
Given the restriction for no average treatment effect α(1) − α(2) = 0, it is
obvious that λ
(1)
Y2
is not identified. For a power analysis of sample data with
the sample means and covariances deviating from the population values the
restricted model might be estimable. For power analysis in this dissertation,
that are based on population parameters, essentially tau-equivalent measure-
ment models are used to avoid identification problems that occur with the
average treatment effect constrained to zero. This identification issue of the
model without the latent covariate will be discussed again in the Monte Carlo
studies below.
The model ignoring the latent covariate is compared to the model in-
cluding the latent covariate with regard to the power to detect an average
treatment effect. This model comparison is done for an average treatment
effect with different effect sizes and with the latent covariate explaining dif-
ferent proportions of the latent outcome variance. As described above the
variance of the structural residual is varied in order to vary the proportion
of variance of the latent outcome that is explained by the latent covariate in
group one. The measure used to report this dependency of η on ξ is again
the coefficient of determination R
2 (1)
η | ξ (see Table 3.1).
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Several parameter settings will be discussed. They include the case with-
out and with an interaction effect present as well as settings for unbalanced
designs, where the number of observations differ between the groups. The
power of the latent multi-group model to detect an average treatment effect
will be analyzed for the case that the multi-group model incorporates the in-
teraction effect as well as the case where interactions are ignored even though
it is present. For certain parameter constellations it will also be necessary
to consider the essentially tau-equivalent measurement model because the
more general tau-congeneric model is not identified (as mentioned above).
Tau-equivalent measurement models are more restricted because the mea-
surement slopes for a latent variable are set equal. This issue is discussed
whenever appropriate.
The general Mplus input for the power analysis of the model including the
latent covariate used in this section is given in Listing A.6 on page 144. Sev-
eral sub-versions of this model are obtained by commenting or uncommenting
lines. As mentioned above the interaction is set to zero by commenting out
line 11 and uncommenting line 12 (i. e. restricting the structural slopes to be
equal across groups). The average treatment effect is set to zero by uncom-
menting line 13. Commenting out line 8 and uncommenting line 9 changes
the measurement models from tau-congeneric to essentially tau-equivalent
for both latent variables (in all groups).
The Mplus input for the latent multi-group model ignoring the latent
covariate is given in Listing A.7 on page 145. The corresponding restricted
model is obtained by uncommenting line 11. Commenting out line 10 and
uncommenting line 9 changes the measurement models from essentially tau-
equivalent to tau-congeneric for both latent variables (in all groups).
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3.5.4 No Treatment-Covariate Interactions
This section compares the latent multi-group model including the latent co-
variate to the model ignoring the latent covariate with regard to the power
to detect an average interaction effect. The cases considered here include
the balanced randomized design with no interactions between treatment and
latent covariate. The effect size of the average treatment effect is varied as
well as the latent outcome variance explained by the latent covariate.
Consider the case where the latent covariate does not explain any variance
of the latent outcome (i. e., β(j) = 0). Given this case the latent multi-
group model involving the latent covariate is not identified for tau-congeneric
measurement models, hence, essentially tau-equivalent measurement models
are used.
Based on the Satorra-Saris method, chi-square difference values are com-
puted for the model without the latent covariate, with the latent covariate
as well as for the model with the latent covariate but the interactions con-
strained to zero. The resulting chi-square difference values are identical for
all three models: 15.95 for a small average effect, 97.68 for a medium average
effect, and 241.12 for a large average effect. Hence, all models yield the same
power for the given parameters.
To verify these results, a Monte Carlo Study is conducted with 1, 000
replications each with a sample size of 1, 000 (500 observations in each group),
with an average effect set to .2. The data is generated with the Mplus input
given in Listing A.9 on page 146. This input also includes the instructions for
the model including the latent covariate, the interaction and tau-congeneric
measurements. The Mplus input for the model without the latent covariate
(using the same data) is given in Listing A.10 on page 147. Several other
models are also estimated, varying the measurement models and whether the
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Table 3.2
Monte Carlo Outcomes for the Power to Detect a Small Average Effect
Given no Interaction, R
2 (1)
η | ξ = 0, and a Sample Size of 1000.
Model M SD rf e rf o C W
1. w/ ξ, TC, w/ int. 0.192 0.073 0.737 699 1076
2. w/ ξ, TC, w/o int. 0.198 0.074 0.734 721 1045
3. w/ ξ, TE, w/ int. 0.199 0.071 0.806 0.817 1000 0
4. w/ ξ, TE, w/o int. 0.199 0.071 0.806 0.817 1000 0
5. w/o ξ, TC 0.199 0.077 0.725 991 468
6. w/o ξ, TE 0.199 0.071 0.806 0.819 1000 0
7. Mean Diff. 0.199 0.069 0.816 1000 0
Note. Models: w/ or w/o ξ = with or without the latent covariate;
TC or TE = tau-congeneric or tau-eqivalent measurement models for all latent
variables; w/ or w/o int. = with or without the interaction; Mean Diff. = two
sample t-test of (Y1 + Y2)/2; M, SD = means and standard deviation of the
1, 000 average effect estimates; rf e = expected relative frequency of significant
tests based on the Satorra-Saris method; rf o = observed relative frequency of
significant tests; C = number of completed models; W = number of warnings.
interaction is set to zero or not.
As mentioned above it is possible to get an causally unbiased estimate
of the average effect simply by the mean difference of the observed outcome
variables. This model is included in the study and named “Mean Diff.”. The
average treatment effect is analyzed with a two sample t-test of (Y1 + Y2)/2.
The results for all models are given in Table 3.2.
Recorded are the mean and the standard deviation of the 1, 000 average
treatment estimates of each model. The means are very close to the true
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parameter .2, indicating unbiasedness for all models. The standard deviations
are similar which indicates similar accuracy of all models.
The proportion of the replications for which the t-value of the average
treatment effect exceeds its 5% critical value is referred to as rf o. This t-
value refers to the incorrect hypothesis of zero average treatment effect. The
study focused on power values close to .8. Due to identification issues (as
discussed above) the Satorra-Saris method is applicable only for the latent
variable models with essentially tau-equivalent measurement models. A good
agreement is obtained for all three models. The observed relative frequencies
(rf o) are close to the power of .86 obtained by the Satorra-Saris method
(rf e).
Although the latent variable models with tau-congeneric measurements
are not identified for the (true) population parameters, they might be identi-
fied if the sample parameters deviate from the population parameters. How-
ever, estimation is not completed for all samples, and even if the model
estimation is completed a large number of warnings indicate caution when
interpreting the results for the latent variable models with tau-congenereric
measurements.
The model estimating the average treatment effect solely with the ob-
served outcome variables (“Mean Diff.”) has no advantage with regard to
the power. However, it is based on less restrictive assumptions than the la-
tent variable models. To summarize the results for the case that the latent
covariate has no effect on the latent outcome, all the models (whether they
include the latent covariate or not, as well as the model based on the ob-
served outcome variable) detect an average treatment effect with the same
power. In other words, if the assumptions of the latent variable model are
met, it does not hurt to include a latent covariate in the model, even if this
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latent covariate does not explain any variance in the latent outcome.
It is of interest, what gain in power to expect if the latent covariate does
actually explain variance of the latent outcome. The following power analysis
therefore considers the case that the latent covariate explains a certain pro-
portion of the latent outcome variance. The measure that is used to reflect
this proportion is again R
2 (1)
η | ξ , the coefficient of determination in group one.
As mentioned above the parameters that are varied in order to vary R
2 (1)
η | ξ
are Var (j)(ζ) and β(1) (see Table 3.1). For a balanced design with no inter-
action present the Satorra-Saris method is used to analyze the power of the
latent variable model without ξ in comparison to the latent variable model
including ξ.
The first result is that the power of the latent model without ξ to detect
a given average effect is the same for all values of R
2 (1)
η | ξ . With β
(1) 6= 0 the
latent variable model including ξ is identified with tau-congeneric measure-
ment models. The second result is that all5 latent variable models including
ξ share the same power to detect an average treatment effect for a given value
of R
2 (1)
η | ξ .
The third and most important finding is that the power of latent models
including ξ increases significantly the more outcome variance ξ explains (i. e.
the larger R
2 (1)
η | ξ ). The power curves in Figure 3.7 show the power of the latent
two-group model to detect a small average treatment effect (α(2)−α(1) = .2)
as a function of sample size as well as R
2 (1)
η | ξ . Here, sample size refers to the
total number of individuals assigned equally to the control and treatment
group (balanced case).
Given the case that the latent covariate does not explain any latent out-
come variance (i. e. β(1) = 0, R
2 (1)
η | ξ = 0), the model including ξ and the
5Models estimating the interaction or setting it to zero as well as models with essentially
tau-equivalent or tau-congeneric measurement models.
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Figure 3.7: The power of the latent two-group model to detect a
small average treatment effect as a function of total sample size and
R
2 (1)
η | ξ for a balanced design and no interaction between treatment
and latent covariate.
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model ignoring ξ yield exactly the same power, represented by the bottom
curve in Figure 3.7. This curve also represents the power of the latent vari-
able model ignoring ξ for any other value of R
2 (1)
η | ξ . The bottom curve shows
that a large total sample size of about 1000 is needed to achieve a power of
.8 if ξ is ignored or it is included but does not explain any latent outcome
variance.
The five curves above this bottom curve represent the power of the latent
variable model including ξ for cases where ξ does explain latent outcome
variance. Figure 3.7 reveals a gain in power for the model including ξ in
comparison to the model without ξ: the larger the proportion of explained
outcome variance the larger this gain in power. Considering the case where ξ
explains 90% of the latent outcome variance, the total sample size required to
achieve a power of .8 for the model including ξ is less than have the sample size
required to achieve the same power with a model ignoring ξ. Similar results
may be obtained for different effect sizes of the average treatment effect.
Figure 3.8 shows the power curves of a medium average effect (α(2) − α(1) =
0.5).
Monte Carlo studies are conducted to verify the results for the balanced
case with no interaction present. A total sample size of 400 (200 in each
group) is chosen. The average treatment effect is set to .2 (i. e. a small effect
size) and R
2 (1)
η | ξ varied between the values .1, .5, and .9. The same models
are used as in the previous Monte Carlo study.
The outcomes are given in Table 3.3. Comparing the means of the esti-
mates for the average treatment effect to its true population value (.2) reveals
that all models provide an unbiased estimate. The standard deviation of all
models ignoring ξ is nearly the same. Comparing the standard deviation
between the models and the three values of R
2 (1)
η | ξ reveals that the models
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Figure 3.8: The power of the latent two-group model to detect a
medium average treatment effect as a function of total sample size
for a balanced design and no interaction between treatment and latent
covariate.
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Table 3.3
Results for the Monte Carlo Study for the Power to Detect a Small Average
Treatment Effect for the Case That R
2 (1)
η | ξ = 0.1, 0.5, or 0.9 and a Total
Sample Size of 400.
Model M SD rf e rf o C W
R
2 (1)
η | ξ = 0.1
1. w/ ξ, TC, w/ int. 0.199 0.107 0.455 0.463 1000 197
2. w/ ξ, TC, w/o int. 0.199 0.107 0.455 0.466 1000 176
3. w/ ξ, TE, w/ int. 0.199 0.107 0.455 0.460 1000 0
4. w/ ξ, TE, w/o int. 0.199 0.107 0.455 0.461 1000 0
5. w/o ξ, TC 0.212 0.122 0.424 938 796
6. w/o ξ, TE 0.200 0.111 0.431 0.450 1000 0
7. Mean Diff. 0.200 0.109 0.448 1000 0
R
2 (1)
η | ξ = 0.5
1. w/ ξ, TC, w/ int. 0.197 0.092 0.581 0.574 1000 0
2. w/ ξ, TC, w/o int. 0.197 0.092 0.581 0.573 1000 0
3. w/ ξ, TE, w/ int. 0.197 0.092 0.581 0.573 1000 0
4. w/ ξ, TE, w/o int. 0.197 0.092 0.581 0.573 1000 0
5. w/o ξ, TC 0.204 0.122 0.364 944 776
6. w/o ξ, TE 0.196 0.111 0.431 0.420 1000 0
7. Mean Diff. 0.196 0.112 0.410 1000 0
R
2 (1)
η | ξ = 0.9
1. w/ ξ, TC, w/ int. 0.203 0.072 0.781 0.806 1000 167
2. w/ ξ, TC, w/o int. 0.203 0.072 0.781 0.806 1000 138
3. w/ ξ, TE, w/ int. 0.203 0.072 0.781 0.806 1000 171
4. w/ ξ, TE, w/o int. 0.203 0.072 0.781 0.805 1000 150
5. w/o ξ, TC 0.218 0.122 0.406 956 728
6. w/o ξ, TE 0.207 0.111 0.431 0.453 1000 0
7. Mean Diff. 0.207 0.110 0.441 1000 0
Note. See Table 3.2 for a description of the abbreviations.
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including the latent covariate estimated the average treatment effect more
precisely. The more latent outcome variance is explained by ξ the larger this
increase in precision.
Given R
2 (1)
η | ξ = .5 estimation problems and warning occurred only for
the latent variable model ignoring ξ with tau-congeneric measurements. As
discussed earlier this is the only model that is not identified for zero average
treatment tests. It can also be seen that for values of R
2 (1)
η | ξ = .1, and .9 the
latent variable models with tau-congeneric measurements produce warnings.
And for R
2 (1)
η | ξ = .9 even the essentially tau-equivalent measurement models
produce some warnings.
In summary the Monte Carlo studies show sufficient agreement between
the expected and observed proportion of significant tests for all models indi-
cating that the Satorra-Saris method is applicable for the considered exam-
ples in which ξ explains latent outcome variance.
3.5.5 Interactions
The main focus of this dissertation is on models that include interactions.
In this section the Satorra-Saris method is applied in order to show how to
analyze the power of the latent multi-group model to detect an average treat-
ment effect in randomized designs if an interaction effect between treatment
and latent covariate is present. The focus will be on interaction effects with
small effect size because this effect size is regarded to be the most relevant
in applied research.
Even with an interaction effect between latent covariate and the treatment
present, it is possible to estimate and test the average treatment effect with
models that ignore the latent covariate (see Figure 3.6). This model is again
compared to models that include the latent covariate. It is important to keep
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in mind that the focus of this section is on the power to detect an average
treatment effect and not to detect an interaction effect. If the focus of a study
is on the interaction effect as well as the average treatment effect, the power
of both effects will have to be considered when choosing the total sample
size.
The model comparison with regard to the power of detecting a small
average treatment effect is again performed with the Satorra-Saris method
by choosing the same parameters as in the last section. The difference here is
that the interaction effect is non-zero and set to β(2)−β(1) = .2. The average
treatment effect is set to α(2) − α(1) = .2 and R2 (1)η | ξ , the proportion outcome
variance explained by ξ, is again varied according to Table 3.1.
The results of the Satorra-Sarris power analysis are shown in Figure 3.9.
Power curves are given for the latent two-group model involving the inter-
action between treatment and ξ (and tau-congeneric measurements). The
different curves refer to the proportion of outcome variance explained by ξ
in the control group. The more outcome variance ξ explains, the larger the
power in order to detect a small average treatment effect.
The additional curve marked with the solid triangle represents the power
of the latent variable model ignoring the latent covariate given R
2 (1)
η | ξ = .9.
The power curves for this model given the other values of R
2 (1)
η | ξ are omitted.
All of these omitted curves are slightly above the curve given but below the
lowest curve of the model that includes ξ. The results of the power analysis
for the given parameters reveals similar results as in the last section where
the interaction effect was set to zero. Given a non-zero interaction the model
that includes the latent covariate detects an average treatment effect with
more power than a model that ignores ξ. The more of the variance of the
latent outcome ξ explains the larger is the gain in power that results from
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Figure 3.9: The power of the latent two-group model to detect a small
average treatment effect as a function of total sample size and R
2 (1)
η | ξ
for a balanced design and a small interaction between treatment and
latent covariate. The curve marked with the solid triangle represents
the power of the latent variable model ignoring the latent covariate
given R
2 (1)
η | ξ = .9.
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including ξ in the model. The total sample size required to achieve a power
of .8 is again less than half for the model including ξ compared to the model
without ξ given R
2 (1)
η | ξ = .9.
Monte Carlo studies are conducted to verify the results of the Satorra-
Saris power analysis. The parameters are set to the same values as just
described for Figure 3.9. The average treatment effect is set to α(2)−α(1) = .2,
the interaction is set to β(2) − β(1) = .2 and R2 (1)η | ξ = 0, .5, or .9. A total
sample size of 600 is chosen with observations again distributed equally to
the two groups. Estimation for the same models as in the previous Monte
Carlo Studies are recorded. For a given parameter set the estimations are
based on the same data for each model.
The outcomes are given in Table 3.4. Comparing the means of the esti-
mates for the average treatment effect to the true population value .2 reveals
that all models provide an unbiased estimate. Comparing the standard de-
viation between the models that include ξ to all the models that ignore ξ
for the three values of R
2 (1)
η | ξ reveals that the models including ξ estimate
the average treatment effect more precisely. The more of the variance of the
latent outcome ξ explains the larger is the increase in precision.
Comparing the expected and observed proportion of significant tests for
all models indicates that the Satorra-Saris method is applicable all considered
examples with interaction effects present. The latent variable model ignoring
ξ with tau-congeneric measurement model is not identified for the population
parameters. Consequently, no value for the expected proportion of significant
tests is given. Based on the 1, 000 samples this model again produces a
large number of warnings and some uncompleted model estimations. The
results for this model have to be interpreted with caution. Given R
2 (1)
η | ξ =
0 the models with tau-congeneric measurement also show a large number
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Table 3.4
Results for the Monte Carlo Study for the Power to Detect a Small Average
Treatment Effect for the Case that R
2 (1)
η | ξ = 0, .5, or .9, a Small Interaction
and a Total Sample Size of 600.
Model M SD rf e rf o C W
R
2 (1)
η | ξ = 0
1. w/ ξ, TC, w/ int. 0.192 0.091 0.586 0.532 966 798
2. w/ ξ, TC, w/o int. 0.196 0.092 0.586 0.532 918 969
3. w/ ξ, TE, w/ int. 0.199 0.091 0.586 0.580 1000 0
4. w/ ξ, TE, w/o int. 0.199 0.091 0.586 0.581 1000 0
5. w/o ξ, TC 0.202 0.101 0.505 973 656
6. w/o ξ, TE 0.199 0.092 0.583 0.576 1000 0
7. Mean Diff. 0.199 0.091 0.568 1000 0
R
2 (1)
η | ξ = 0.5
1. w/ ξ, TC, w/ int. 0.202 0.077 0.736 0.739 1000 0
2. w/ ξ, TC, w/o int. 0.202 0.077 0.737 0.738 1000 0
3. w/ ξ, TE, w/ int. 0.202 0.077 0.736 0.741 1000 0
4. w/ ξ, TE, w/o int. 0.202 0.077 0.737 0.741 1000 0
5. w/o ξ, TC 0.205 0.105 0.496 966 756
6. w/o ξ, TE 0.199 0.097 0.539 0.521 1000 0
7. Mean Diff. 0.199 0.098 0.517 1000 0
R
2 (1)
η | ξ = 0.9
1. w/ ξ, TC, w/ int. 0.199 0.062 0.893 0.887 1000 88
2. w/ ξ, TC, w/o int. 0.199 0.062 0.895 0.889 1000 139
3. w/ ξ, TE, w/ int. 0.199 0.062 0.893 0.888 1000 97
4. w/ ξ, TE, w/o int. 0.199 0.062 0.895 0.888 1000 151
5. w/o ξ, TC 0.206 0.106 0.501 966 857
6. w/o ξ, TE 0.201 0.098 0.526 0.536 1000 0
7. Mean Diff. 0.201 0.100 0.533 1000 0
Note. See Table 3.2 for a description of the abbreviations.
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of warnings and several uncompleted model estimations. For R
2 (1)
η | ξ = .9
warnings are recorded for all latent variable models but all model estimations
are completed.
To summarize the results of the power analysis for balanced randomized
designs, it can be stated that the Satorra-Saris method provides sufficient
agreement between the predicted power values and the results of the Monte
Carlo studies. The examples included the case without and with an interac-
tion effect present and models that include and ignored the interaction.
3.5.6 Unbalanced Designs
This section discusses effects on power of deviations from balanced data.
First, consider again the simple case without an interaction effect present
and the latent covariate explaining no latent outcome variance. For this
case, Figure 3.10 shows, how the power varies as a function of the proportion
of treatment-group observations for a given total sample size of 250, 500, 750,
and 1, 000. The power is the same for all latent models, whether they include
or ignore ξ and whether they fix the interaction to zero or not. The power
curves are symmetric around the balanced case where the proportion is .5.
Choosing an unbalanced design in favor of more treatment or more control
observations reduces the power to detect an average treatment effect.
Figure 3.11 shows the power of the latent variable model including ξ to
detect a small average treatment effect for the case that the latent covariate
explains 90% of the latent outcome variance in the control group (R
2 (1)
η | ξ =
0.9) and no interaction present. The power of the latent variable model
ignoring ξ for this case is the same as shown in Figure 3.10. Comparing
the model including ξ to the model without ξ (comparing Figure 3.11 vs.
Figure 3.10) indicates the gain in power that results from including ξ in the
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Figure 3.10: Power of the latent variable model (with or without ξ) to
detect a small average treatment effect as a function of the proportion
of cases in treatment group and total sample size given no interaction
and ξ explaining 90% of outcome variance in the control group.
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Figure 3.11: Power of the latent variable model including ξ to detect
a small average treatment effect as a function of the proportion of
cases in treatment group and total sample size given no interaction
and ξ explaining 90% of outcome variance in the control group.
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model. Figure 3.11 also shows symmetric power curves around the balanced
case. The balanced case again yields the highest power and should be favored
over the unbalanced design. It also should be mentioned that without an
interaction effect present, the latent variable models including ξ share the
same power whether they include the interaction or fix it to zero.
I now turn to the case with an interaction effect present. Figure 3.12
shows how the power varies as a function of the proportion of treatment-
group observations for a given total sample size of 250, 500, 750, and 1, 000.
The power of the latent variable model including ξ and the interaction is
given for the case of a small average effect, a large interaction effect and ξ
explaining a proportion of 90% of the latent outcome variance in group one.
The power curves are not symmetric around the balanced case where the
proportion is .5. Choosing an unbalanced design in favor of more treatment
observations is better than choosing an unbalanced design in favor of more
control observations. This is because the outcome variance is larger in the
treatment group than in the control group, whereas the reverse would hold
if the treatment group variances were smaller. The reverse situation was
verified by using an interaction effect of negative value that induced lower
treatment group variance.
As mentioned before the average treatment effect may be estimated by
a model that includes the latent covariate but fixes the interaction to zero
even if an interaction is present. In the following, the latent model with
the interaction fixed to zero is compared to the model that estimates the
interaction with regard to the power to detect an average treatment effect.
Figure 3.13 shows the power of the latent variable model with an inter-
action effect fixed to zero for the same parameter values used in Figure 3.12
where an interaction effect is present and included in the model. Comparing
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Figure 3.12: Power of the latent variable model including ξ and the
interaction in order to detect a small average treatment effect as
a function of the proportion of cases in treatment group and total
sample size given a large interaction effect and ξ explaining 90% of
outcome variance in the control group.
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Figure 3.13: Power of the latent variable model fixing the interaction
to zero in order to detect a small average treatment effect as a func-
tion of the proportion of cases in treatment group and total sample
size given a large interaction and and ξ explaining 90% of outcome
variance in the control group.
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Figure 3.12 and 3.13 shows that the power curves are not identical. The
model that ignores the interaction has slightly more power around the bal-
anced case where the proportion is about .5 and the model that includes
the interaction has slightly more power for small proportions of cases in the
treatment group.
Figure 3.14 explicitly compares the two models for a total sample size
of 750. It should be noted that the parameters for Figure 3.14 are chosen
to show the largest power difference for the two compared models. The
difference in power of the model including the interaction vs. the model
without the interaction are smaller for all other sets of parameters used in this
analysis. No differences are found for the case with no interaction present.
The differences of the compared models are small and may be considered
negligible. A Monte Carlo study is conducted for the unbalanced design
with 20% of cases in the treatment group, in order to verify the validity of
these differences. The total sample size is 750 (150 observations in treatment
group), the interaction parameter is set to a value of .8, and the average
treatment effect is set to a value of .2. These parameters are chosen because
the Satorra-Saris method yielded the largest advantage of the model including
the interaction. The results are given in Table 3.5. All models estimate the
average treatment effect without bias. The models differ in power. The
models including ξ and the interaction show the highest detection rate of an
average treatment effect indicating that the Satorra-Saris method correctly
predicts the gain in power resulting from including the interaction in the
model. Note however that the parameters for this example are chosen to
resemble the most extreme case predicted by the Satorra-Saris method and
that even for this example the difference is negligible to some extend.
We have seen that the Satorra-Saris method works very well to estimate
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Figure 3.14: Power to detect an average treatment effect of the latent
variable model including the interaction and the model without the
interaction as a function of the proportion of cases in treatment group
given a large interaction effect and a total sample size of 750.
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Table 3.5
Results for the Monte Carlo Study for an Unbalanced Design (20% of
Cases in Treatment Group) Given a Large Interaction and a Total Sample
Size of 750.
Model M SD rf e rf o C W
1. w/ ξ, TC, w/ int. 0.196 0.088 0.606 0.617 1000 327
2. w/ ξ, TC, w/o int. 0.196 0.096 0.538 0.549 1000 128
3. w/ ξ, TE, w/ int. 0.196 0.088 0.606 0.617 1000 326
4. w/ ξ, TE, w/o int. 0.196 0.096 0.538 0.545 1000 130
5. w/o ξ, TC 0.208 0.163 0.247 927 941
6. w/o ξ, TE 0.194 0.156 0.245 0.241 1000 2
7. Mean Diff. 0.194 0.159 0.411 1000 0
Note. See Table 3.2 for a description.
power of the discussed latent multi-group model with regard to detect in-
teraction effects as well as average treatment effects (for the considered ex-
amples). In summary, this chapter provides a description how to analyze
average treatment effects based on models that include latent covariates and
interactions between these latent covariates and the treatment. Standard
SEM software may be used to implement the estimation and the test of the
average treatment effect. It was also shown how to use Mplus in order to
study power based on the Satorra-Saris method. The discussion was limited
to randomized research designs. The following chapter will expand this topic
to research designs that do not incorporate randomization.
Chapter 4
Non-randomized Designs
The last chapter described how multi-group structural equation modeling
can be used to analyze average effects and interaction effects in the same
modeling framework given that randomization is successfully implemented
in the research design. In this chapter, several models are discussed and
compared that may be used if randomization is not implemented in the design
of a study. The key difference is that without randomization the expected
values of the latent covariate might differ across groups. The multi-group
approach described in the last chapter however, requires the assumption that
these expected values are equal across groups. If this assumption does not
hold, this chapter presents single-group as well as multi-group models that
are applicable to analyze average effects. Monte Carlo studies are described
that compare the performance of these approaches.
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4.1 AMulti-group Approach to Analyze Non-
randomized Designs
The average treatment effect was specified in Equation 3.7 for the model in-
volving an interaction between a treatment and a latent covariate. Applying
the multi-group model yielded the identical specification with the multi-group
parameters given in Equation 3.22, which is repeated here
AE 2−1 = α(2) − α(1) +
(
β(2) − β(1))E (ξ). (4.1)
It was mentioned that E (ξ) is not a parameter of the multi-group model.
The solution for a randomized design is to set the group specific mean equal
in order to estimate the grand mean of the latent covariate. This is of course
not feasible if the group means differ. Considering the following property
E (ξ) = E (ξ |X=1) P (X=1) + E (ξ |X=2) P (X=2), (4.2)
shows, that Equation 4.1 can be written by replacing E (ξ) with the two
group specific means of ξ, which are parameters in the multi-group model.
The average effect is then specified as
AE 2−1 = α(2) − α(1)
+
(
β(2) − β(1)) (E (ξ |X=1) P (X=1) + E (ξ |X=2) P (X=2)). (4.3)
Two cases have to be distinguished. First, the treatment probabilities
P (X=1) and P (X=2) are fixed terms. This is the case, for example, if they
are fixed by the research design. Second, these terms are observed as they
(randomly) occur. In the first case, the values for the two terms may be
treated as fixed numbers whereas in the second case they are parameters of
the model, that are estimated by the observed relative group sizes.
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Currently, standard structural equation software does not allow to include
these treatment probabilities as parameters in a multi-group model. The
observed values have to be written in the model and are always treated
as fixed numbers. Consequently, no standard errors and covariances with
other parameters are obtained. Using these values in constraints to test
average effects may lead to problems (see, e. g., Nagengast, 2006). Monte
Carlo Studies are described later that test the performance of the multi-group
model (see Listing 4.4 on page 125 for a Mplus input example).
4.2 A Single-group Approach to Analyze Non-
randomized Designs
So far the interaction between the treatment variable and the latent co-
variate has been treated with conventional structural equation modeling us-
ing multiple-group analysis, where the treatment variable (an observed un-
ordered or categorical variable) represents the groups. It was shown in the
last section, that it is possible to use multiple-group analysis to test interac-
tion as well as average (or main) effects simultaneously. This was considered
impossible beforehand (see, e. g Jaccard & Wan, 1996, p. 41). However as
stated in the last section, there might be problems if the relative groups sizes
are observed as they (randomly) occur.
The solution to this problem described in this section is to use a single-
group approach that models the interaction between the treatment variable
and the latent covariate. This type of interaction cannot be handled by
conventional SEM. Special interaction modeling involving latent variables is
needed, for example using the Joreskog-Yang approach (Jo¨reskog & Yang,
1996), 2SLS (Bollen, 1996), or the full-information maximum-likelihood ap-
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proach of Klein and Moosbrugger (2000).
The interaction needed for the single-group model fits into the Mplus
latent variable framework so that full-information maximum-likelihood esti-
mation is possible (Asparouhov & Muthe´n, 2002). Klein and Moosbrugger
(2000) pointed out the important efficiency and power advantages for inter-
action modeling by use of full-information maximum-likelihood estimation as
compared to limited-information estimators such as the Joreskog-Yang and
2SLS approaches.
Consider again the interaction between the treatment and the latent co-
variate given in Equation 3.1, which is repeated here1
E (η |X, ξ) = α + β1IX=2 + β2ξ + β3IX=2ξ. (4.4)
The Mplus approach to handling the interaction in Equation 4.4 uses a
random slope variable (B. O. Muthe´n & Asparouhow, n.d.). The regression
in Equation 4.4 can be written using two equations involving a random slope
variable r and the residual ζ
η = α + β1IX=2 + β2ξ + rIX=2 + ζ (4.5)
r = 0 + β3ξ + 0. (4.6)
In Equation 4.5, a random slope is defined for the treatment indicator
IX=2. In Equation 4.6, the random slope is taken to be the same as the
latent covariate ξ, except for a regression slope β3, the interaction coefficient.
In Equation 4.6, r is a latent variable that only contributes a single additional
parameter. The corresponding intercept and the residual are set to zero. The
two equations 4.5 and 4.6 indicate that the model is specified as a general
1Note that unlike conventional SEM (no interaction), the variance of η conditional on
ξ changes as a function of ξ.
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Figure 4.1: The SEM model extended to random slopes implemented
in Mplus in order to include the interaction between the latent co-
variate and the treatment variable. The random slope variable, sym-
bolized with the dot on the path from IX=2 to η, constitutes a latent
variable that only contributes the interaction parameter β3 to the
model.
structural equation model extended to random slopes. Such random slopes
models can be handled in Mplus and will be used in the following to estimate
average treatment effects.
The model described in Equation 3.1 to 3.4 fits in this extended SEM
model. Figure 4.1 illustrates how this particular model is implemented in
Mplus (compare to Figure 3.1 and 3.2). It is clear that r is a latent variable
that only contributes the interaction parameter β3 to the model. The arched
double arrow between ξ and IX=2 describes the correlation between the latent
covariate and the treatment indicator. Given a non-randomized design this
correlation can not be assumed to be zero (and the group means of ξ to
equal).
At this point I want to mention that the random slope approach as it is
described here assumes the same variances of the structural residual across
groups. The previously described multiple group approach can model group
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specific variances of the structural residual. Because the focus of this dis-
sertation is on the average treatment effect, different error variance of the
structural residual are no considered here. However there are theories that
might imply different variances of the structural residual (see, e. g. Steyer,
2005) and it might be possible to extend the outlined random slope approach
to incorporate these differences.
In the following, this random slope approach is used to analyze the average
treatment effect. Again two ways of scaling the latent variables ξ and η will
be discussed. Just like in the section describing the multiple-group analysis
we will see that the default parameter settings of Mplus simplify the analysis
of the average treatment effect.
4.2.1 Testing the Average Treatment Effect
One way to scale the latent variables ξ and η is to set the measurement
slope of the first observed variable for each latent variable to one (i. e.,
λZ1 = λY1 = 1). The first way described here completes the scaling of ξ by
setting its mean to zero
E (ξ) = 0. (4.7)
The scaling of η is completed by setting the structural intercept of η to zero
α = 0. (4.8)
For the given model the average treatment effect was given in Equation 3.7
on page 55. It is repeated here
AE 2−1 = β1 + β3 E (ξ). (4.9)
If ξ is scaled by setting E (ξ) = 0, then the average treatment effect
is identified by β1, the first order effect of the indicator variable. Hence,
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1 DATA: FILE = data.dat;
2 VARIABLE: NAMES = Y1 Y2 Z1 Z2 X;
3 USEVARIABLES = Y1 Y2 Z1 Z2 IX2;
4 DEFINE: IX2 = 0; IF(X EQ 2) THEN IX2 = 1;
5 ANALYSIS: TYPE = RANDOM;
6 ALGORITHM = INTEGRATION;
7 MODEL: ETA BY Y1-Y2;
8 XI BY Z1-Z2;
9 IX2 WITH XI;
10 ETA ON XI;
11 ETA ON IX2;
12 R | ETA ON IX2;
13 R ON XI;
14 R@0;
15 [R@0]; 
Listing 4.1: Mplus input to model the interaction between ξ (XI) and IX=2
(IX2) using a random slope variable r (R).
estimating the average treatment effect is simply done by estimating β1.
No further specification of additional parameters is necessary. The standard
error estimate of β1 can be used to apply t-testing in order to test the average
treatment effect against a hypothetical value. It is not necessary to manually
compute the standard error estimate via the delta method.
Mplus offers two ways to implement this procedure. One way is to explic-
itly specify the random slope variable. Listing 4.1 gives the corresponding
Mplus input for the given example. This method is discussed first because
it shows how the random slope approach is implemented. The second way
is more intuitive because the interaction is specified directly with an XWITH
statement. Listing 4.2 gives the corresponding input for the given example
and is discussed after the random slope specification.
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1 DATA: FILE = data.dat;
2 VARIABLE: NAMES = Y1 Y2 Z1 Z2 X;
3 USEVARIABLES = Y1 Y2 Z1 Z2 IX2;
4 DEFINE: IX2 = 0; IF(X EQ 2) THEN IX2 = 1;
5 ANALYSIS: TYPE = RANDOM;
6 ALGORITHM = INTEGRATION;
7 MODEL: ETA BY Y1-Y2;
8 XI BY Z1-Z2;
9 IX2 WITH XI;
10 R | XI XWITH IX2;
11 ETA ON IX2 XI R; 
Listing 4.2: Mplus input to model the interaction between ξ (XI) and IX=2
(IX2) using the XWITH option. This input is equivalent to the one using the
random slope specification given in Listing 4.1.
By selecting the analysis type as RANDOM, a model with random slopes
will be estimated. The default estimator (MLR), a maximum likelihood esti-
mator with robust standard errors using a numerical integration algorithm
will be used. The standard errors are robust to non-normality and are com-
puted using a sandwich estimator (L. Muthe´n & Muthe´n, 2004, p. 432).
The computations require numerical integration which becomes increasingly
more computationally demanding as the number of variables and sample size
increase. The default integration uses rectangular (trapezoid) numerical in-
tegration with a default of 15 integration points per dimension. The model
estimation uses full-information maximum-likelihood (L. Muthe´n & Muthe´n,
2004; see also Asparouhov & Muthe´n, 2002; Klein & Moosbrugger, 2000).
Similar to the multi-group model, the two latent variables are defined
by lines 7 and 8. The measurement slopes of Y1 and Z1 are set to one per
default. The mean of ξ is set to zero per default. Line 9 sets the correlation
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between ξ and IX=2 free, this line is required because the default is to set this
correlation to zero. Line 10 and 11 specify that η is regressed on ξ and IX=2
with the intercept set to zero per default. The remaining lines implement the
interaction in this regression. Line 12 specifies r as a random slope variable in
the regression of η on IX=2. Line 13 to 15 specify this random slope variable
to be the same as ξ, except for a scaling factor, the interaction coefficient
β3. Line 13 specifies this regression that contributes β3 to the model, line 14
and 15 specify the intercept and the residual of this regression to be zero
respectively.
Mplus also offers a more intuitive way to specify this interaction. List-
ing 4.2 gives the input corresponding to Listing 4.1. Line 10 of Listing 4.2
defines the “interaction variable” R, which then occurs in line 11 (besides IX2
and XI) as a regressor on which η is regressed on. Both specifications are
treated to be identical throughout the following discussion of the model and
the Monte Carlo studies2.
The summary of the analysis results given in theMplus output contain the
log-likelihood for the analysis model but no chi-square statistic. Model differ-
ence testing is possible using the log-likelihood based on a method developed
by Satorra (2000). It is however not needed here. The interested reader will
find more information on the Mplus website under Difference Testing Using
the Loglikelihood (n.d.).
The parameter estimation and test for the interaction and the average
treatment effect do not require model difference testing and are readily avail-
able from the output under the model results. The parameters of special
2The two methods differed for a few data sets of the Monte Carlo studies below with
regard to their default starting values. The XWITH statement produced slightly less warn-
ings. The performance of both methods with regard to parameter estimation and overall
model estimation was almost identical.
CHAPTER 4. NON-RANDOMIZED DESIGNS 114
interest here include β3, the interaction, which is found in the row labeled
R ON XI, as well as β1, the average treatment effect, which is found in the
row labeled ETA on IX2. The standard errors (labeled S.E.) produced dur-
ing model estimation are determined by the MLR estimator described above.
The values labeled Est./S.E. contain the values of the parameter estimate
divided by the standard error (column 1 divided by column 2). This statisti-
cal test is an approximately normally distributed quantity (z-score) in large
samples. The critical value for a two-tailed test at the .05 level is an absolute
value greater than 1.96.
We have seen how Mplus can be used to analyze the interaction between a
treatment and a latent variable as well as the average treatment effect. The
described model uses a structural equation modeling framework extended to
random slopes. The single-group model is estimated using full-information
maximum-likelihood and avoids potential problems that may be involved in
the corresponding multi-group approach mentioned in section 4.1.
4.3 Monte Carlo Studies
In this section, Monte Carlo Studies are conducted in order to assess the
performance of the single-group approach described in the previous section
as well as the multi-group approach described in section 4.1 with regard
to estimating and testing the average treatment effect. It was argued that
the multi-group approach is more flexible than the single-group approach,
because it allows different variances of the structural residual across groups.
However, it was also argued that the multi-group approach does not treat
all model parameters as such and problems might arise if the treatment
probability P (X=2) is estimated from the sample.
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The single-group approach on the other side avoids this problem because
it allows to model the average treatment effect in a sound manner. It is how-
ever much more computationally demanding than the multi-group approach
and currently only implemented in Mplus. The following Monte Carlo studies
are conducted to address theoretical concerns and to give advice to practi-
tioners. The comparison focuses on the biasedness of the estimators of the
average treatment effect as well as the biasedness of the standard error es-
timators of the average treatment effect. Because the data generation for
these Monte Carlo studies is more complex than in the Monte Carlo studies
for randomized designs it is discussed in detail.
4.3.1 Data Generation
In the Monte Carlo studies for randomized designs Mplus was used to gen-
erate and analyze the data (see Chapter 3.5). In the following Monte Carlo
studies, the data is generated with the statistical programming environment
R (R Development Core Team, 2006) and analyzed with Mplus. The data is
generated in order to simulate a non-randomized design where the treatment
assignment is expected to depend on other variables. Here, the treatment as-
signment depends only on the latent covariate ξ. Hence, including the latent
covariate in the analysis yields causally unbiased estimates for the condi-
tional and average treatment effects (see Steyer et al., 2007, for a detailed
discussion on the topic on causality).
A logistic regressive dependency is chosen in order to model the depen-
dency of the assignment probabilities on the latent covariate. The program
to generate data is given in Listing B.2 on page 149. It is written in order to
simulate the following random experiment: From a population of units draw
one unit, record the values of two observed variables Z1 and Z2 that measure
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the latent covariate ξ. Randomly assign the unit to one of the treatment
groups. This random assignment is not completely randomized. Instead, the
assignment probabilities for each group depend on the latent covariate and
are determined by logistic functions
P (X=2 | ξ) = 1/ (1 + exp(l0 + l1ξ)) (4.10)
P (X=1 | ξ) = 1− P (X=2 | ξ). (4.11)
The treatment is applied and the values of the two observed outcome variables
Y1 and Y2 that measure the latent outcome variable η are recorded. The
value of the latent outcome variable η depends on the treatment and the
latent covariate based on the following equation
η = α + β1IX=2 + β2ξ + β3IX=2ξ + ζ. (4.12)
The values for ζ, the residual of this regression, are taken from a normally
distributed random variable with expected value zero and variance Var(ζ) =
.5.
The four observed variables are computed based on the measurement
models described in Equations 3.3 to 3.4 involving normally distributed mea-
surement residuals, Z1 , Z2 , Y1 , and Y2 each with variance .5. All residuals
are generated independent from each other and the latent variables.
The difference to the Monte Carlo Studies in Chapter 3.3 is that the
treatment assignment is not (completely) randomized. Instead, the treat-
ment assignment is conditionally randomized with the assignment probabil-
ities depending on the latent covariate. In the current version of Mplus it
is not possible to generate such data internally (Linda Muthe´n, personal
communication, May 16, 2006). The data is generated externally using R.
Listing B.2 on page 149 gives the corresponding code.
CHAPTER 4. NON-RANDOMIZED DESIGNS 117
This data generation proceeds in several steps (all parameters given in
parentheses refer to the program code in Listing B.2). The values for the
latent covariate ξ (xi) are generated by drawing N units from a standard
normal distribution (i. e. E (ξ) = 0 and Var(ξ) = 1).
The values of each observation on the latent covariate ξ are then used
to determine the assignment probabilities for the treatment groups. The
values for the treatments are taken from a random variable with a discrete
probability distribution, which takes value 2 with conditional probability
P (X=2 | ξ) and value 1 with conditional probability 1 − P (X=2 | ξ). The
values of these conditional assignment probabilities are determined by the
logistic functions given in Equations 4.10 and 4.11.
The parameters of these functions, l0 (l0) and l1 (l1), are varied in order
to represent different situations. The threshold parameter l0 (l0) varies in
order to change the (unconditional) assignment probabilities P (X=1) and
P (X=2), in other words the expected relative group sizes. The slope pa-
rameter l1 (l1) varies in order to change the dependency of the treatment
assignment on the latent covariate.
The values of η are calculated based on the regression given in Equa-
tion 4.12. The structural intercept α as well as the first order effect of the
treatment indicator β1 are fixed to zero. This is done to insure that the
hypothesis of no average treatment effect in the population is true. Given
E (ξ) = 0 and β1 = 0, the average treatment effect is zero (see Equation 4.9
on page 110).
The first order effect of ξ is set to β2 =
√
.5 in order to achieve a moderate
dependency of η on ξ given that no interaction effect is present. The inter-
action effect β3 is set by choosing a value for b3. The structural part of the
SEM model is completed by adding the structural residual ζ, a normally dis-
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tributed random variable with expected value zero and variance Var(ζ) = .5.
With no interaction effect present (i. e. β3 = 0), the latent covariate can be
expected to explain 50% of the variance of η.
The values for the observed variables Z1, Z2, Y1, and Y2 measuring the
latent covariate and the latent outcome respectively are computed according
to the measurement models given in Equations 3.3 and 3.4. For simplicity
the parameters3 are set to the (constant) values:
νZk = νYk = 0 (4.13)
λZk = λYk = 1 (4.14)
Var(Zk) = Var(Yk) = 0.5, (4.15)
where k = 1, 2. The values for the measurement residuals Z1 , Z2 , Y1 , and
Y2 are taken from independently normally distributed random variables each
with expected value zero and variance .5.
The consequences for the distributions of the involved variables are as
follows. Although ξ is normally distributed, the distribution of ξ conditional
on X (i. e., per group) deviates from normality due to the logistic regressive
dependency of X on ξ. Hence, the distributions of Z1 and Z2 conditional on
X are non-normal. The distribution of η deviates from normality due to the
interaction. The distribution of η conditional on X deviates from normality
due to the non-normality of the distribution of ξ conditional on X. Hence,
the distribution of Z1 and Z2 as well as the conditional distribution of Y1 and
Y2 given treatment are non-normal.
Despite these deviations from non-normality the following assumptions
3The parameters of the measurement models are chosen to be identical to the param-
eters used in the Monte Carlo studies for randomized designs described in Chapter 3.3
(see Equation 3.33). The reliabilities differ to some extend from the reliabilities given in
Chapter 3.3 due to the dependency of X on ξ.
CHAPTER 4. NON-RANDOMIZED DESIGNS 119
are met. The structural residual ζ is normally distributed and independent
from ξ. Both properties also hold conditional on X. The distributions of
Z1 and Z2 as well as the distribution of Z1 and Z2 conditional on X do
not depend on η, ζ, Y1, or Y2. Given these assumptions, minimizing the
likelihood function of the general latent variable framework for the multiple
group analysis given in Equation 3.14 leads to maximum likelihood estima-
tion regardless of described deviations from normality (Bollen, 1989, 126–127;
Johnston, 1984, 281–285; Jo¨reskog, 1973, 94).
Two Monte Carlo studies are conducted. The first one considers the
case where the two (unconditional) assignment probabilities P (X=1) and
P (X=2) are equal. The threshold parameter of the logistic regression of X
on ξ is set to l0 = 0 (balanced case). In the second study, the assignment
probabilities are unequal. The probability of being assigned to the control
group is about twice the probability of being assigned to the treatment. In
both Monte Carlo studies the data was analyzed with three methods:
• Mplus approach to handling interactions by extending SEM with a ran-
dom slope variable; referred to as the single-group approach (see sec-
tion 4.2)
• the multi-group-approach with the assignment probability (written in
the constraint for the average treatment) fixed to the true population
value (see section 4.1, and Equation 4.16 below)
• the multi-group-approach with the assignment probability estimated
from each replication
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4.3.2 Monte Carlo Study with Equal Group Sizes
In the first Monte Carlo study, the threshold of the logistic regression of X on
ξ, is set to l0 = 0 and held constant. Hence, the (unconditional) assignment
probabilities are P (X=1) = P (X=2) = .5. Note however, that the actual
relative group sizes vary from sample to sample.
Design
The performance of the average treatment effect estimators are studied by
systematically varying the following parameters4 in a fully crossed factorial
design: total sample size (N ), dependency of X on ξ (l1), and the interaction
(b3).
The total sample size is either set to N = 400 or 1000. These values
are chosen based on the discussion of the power analyzes in chapters 3.5
to 3.5.3. As shown, a sample size of 400 will certainly not be sufficient to
detect a small interaction effect and a small average treatment effect with a
desirable power of about .8. Nevertheless, such a sample size is often used in
behavioral studies and is therefore included in the study.
The dependency of X on ξ is varied by choosing two different values
for the slope parameter l1 = −1 and l1 = −5. The corresponding expected
dependencies of X on ξ are expressed in terms of the correlation between
IX=2 and ξ. For l1 = −1 numerical integration yields an expected correlation
of Corr(ξ, IX=2) ≈ 0.413 and is referred to as a moderate dependency of
the treatment on the latent covariate. For l1 = −5 the expected correlation
between the latent covariate and the treatment indicator is Corr(ξ, IX=2) ≈
0.751 and is referred to as a strong dependency of the treatment on the latent
covariate.
4The parameters in the parentheses refer to the R input given in Listing B.2.
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The interaction between X and ξ is varied between the following values
β3 = 0, .2, .5, .8, 1.5, 3, and 10. The interpretation of these values calls for
measures of effects size. The classification used here follows the outline in
chapter 3.5. Throughout chapter 3.5 the effect size of the interaction is deter-
mined by dividing the interaction parameter by Var(η |X=1), the variance
of η in the control group. All parameters in the power analysis for random-
ized designs are chosen so that Var(η |X=1) = 1, yielding equivalence of
interaction parameter and corresponding effect size.
Given the data generation for non-randomized designs,
Var(η |X=1) depends on the regression coefficients and additionally on the
parameters of the logistic regression of X on ξ. Hence, changing the param-
eters of the logistic regression would change the effect size of the interaction.
The effect size of the interaction would have to be adjusted according to
the dependency of X on ξ. Given the moderate dependency of X on ξ (i. e.
l1=-1) the variance of η in group one is approximately .91. Hence, the effect
size of the interaction would be about 10% larger than the corresponding
interaction parameter. Given the strong dependency of X on ξ (i. e. l1=-5)
the variance of η in group one is approximately .72. Hence, the effect size
of the interaction would be 30% larger than the corresponding interaction
parameter.
To avoid this complication, the measures of effect size used for the inter-
action effect are determined by ignoring the dependency of X on ξ. Given
no dependency of X and ξ the variance of η in group one remains one (i. e.,
Var(ξ |X=1) = 1) thus yielding equivalence of interaction parameter and
corresponding effect size. Consequently, the interpretation of the effect sizes
of the interaction parameter is invariant to changes of the dependency of X
on ξ and is comparable to the effect sizes given in chapter 3.5.
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Following Cohen’s (1988) classification, the values of the interaction pa-
rameter β3 = .2, .5, .8 are referred to as small, medium, and large interaction
effects respectively. The values β3 = 1.5, and 3 are both referred to as very
large interaction effects. The value β3 = 10 will seldom occur in real data
and is included here merely for theoretical purposes.
4.3.3 Data analysis
The data are analyzed with the three methods listed above. First, the single-
group approach using the Mplus SEM model extended to random slopes is
applied using the code given in Listing 4.3. This method will be referred to
as single-group approach . The code is almost the same as the one given
in Listing 4.2. The only difference between Listing 4.3 and Listing 4.2 occur
in line 1 and 2, stating that the data to be analyzed are of type MONTECARLO,
meaning that many data sets (replications) are to be analyzed with the cor-
responding file names listed in mcreplist.dat.
The outputs of the code in Listing 4.3 include a summary of the overall
model fit containing mean and standard deviation of the log-likelihood test
statistic over the replications of the Monte Carlo analysis. The summary of
results includes the true population value for each parameter, the average
of the parameter estimates across replications, the standard deviation of
the parameter estimates across replications, the average of the estimated
standard errors across replications, the means square error for each parameter
(M.S.E.), 95% percent coverage, and the proportion of replications for which
the null hypothesis that a parameter is equal to zero is rejected at the .05
level.
The main focus of this study is on the average treatment effect. The de-
fault scaling of the latent variables is the same as described in section 4.2.1,
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1 DATA: FILE = mcreplist.dat;
2 TYPE = MONTECARLO;
3 VARIABLE: NAMES = Y1 Y2 Z1 Z2 X;
4 USEVARIABLES = Y1 Y2 Z1 Z2 IX2;
5 DEFINE: IX2 = 0; IF(X EQ 2) THEN IX2 = 1;
6 ANALYSIS: TYPE = RANDOM;
7 ALGORITHM = INTEGRATION;
8 MODEL: ETA BY Y1-Y2;
9 XI BY Z1-Z2;
10 IX2 WITH XI;
11 R | XI XWITH IX2;
12 ETA ON IX2 XI R; 
Listing 4.3: Mplus input for the Monte Carlo study using the single-group
approach in order to estimate and test the average treatment effect.
where it was shown that the average treatment effect is identified by β1,
the first order effect of the indicator for treatment two. This parameter is
labeled ETA ON IX2. The average of the parameter estimates across replica-
tions (value of column two ESTIMATES Average) is used to assess the bias
(see below). Column three, labeled Std. Dev., gives the standard deviation
of the parameter estimates across the replications. Because the number of
replication is 1000, this value is considered to be the population standard er-
ror. Column four, labeled S.E. Average, gives the average of the estimated
standard errors across replications. These two values are used to assess the
standard error bias (see below).
The data are also analyzed with two versions of the multi-group ap-
proach described in chapter 4.1. In both versions the latent variables are
scaled so that the mean of ξ in group one and the structural intercept of η
in group one (α(1)) are both zero. Hence, the specification of the average
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treatment effect (Equation 4.3) reduces to
AE 2−1 = α(2) +
(
β(2) − β(1))E (ξ |X=2) P (X=2). (4.16)
The first version uses P (X=2), the assignment probability of the popula-
tion, whereas the second version uses P̂ (X=2), the assignment probability
estimated from the sample by the proportion of cases in group two. The
first version is applicable if the (relative) group sizes are under control by
the researcher. In this case, the quantity used in the constraint is fixed and
does not change between replications.
The second case, however, is more often encountered in applied research
studies. The (population) probabilities are not under control by the re-
searcher and are not known. Hence, the assignment probability has to be
estimated by the proportion of cases in group two which (randomly) occurs
in the sample. Because Mplus (and other standard SEM) software does not
allow to treat this quantity as a parameter in a multi-group model, the ob-
served value is simply written in the model constraint. Consequently, no
standard errors and covariances with other parameters are obtained. The
Monte Carlo study investigates (for a few examples) potential shortcomings
of this method.
The code for version one (using the population treatment probability) is
given in Listing 4.4. Line 11 specifies the average treatment effect with a non-
linear constraint according to Equation 4.16. The MONTECARLO statement is
used to obtain summary results over the replications.
The output of the code in Listing 4.4 includes a summary of the over-
all model fit containing mean and standard deviation of the chi-square test
statistic over the replications of the Monte Carlo analysis. The summary
of results includes information about the same measures as the output of
Listing 4.3. The results for the average treatment effect are found under
New/Additional Parameters.
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1 DATA: FILE = mcreplist.dat; TYPE = MONTECARLO;
2 VARIABLE: NAMES = Y1 Y2 Z1 Z2 X;
3 GROUPING = X (1 = G1 2 = G2);
4 ANALYSIS: TYPE = MEANSTRUCTURE;
5 MODEL: XI BY Z1 Z2; ETA BY Y1 Y2; ETA ON XI;
6 MODEL G1: ETA ON XI (BE1);
7 MODEL G2: ETA ON XI (BE2);
8 [XI] (MXI2);
9 [ETA] (AL2);
10 MODEL CONSTRAINT: NEW(AE);
11 AE = AL2 + (BE2 - BE1) * MXI2 * 0.5;
12 OUTPUT: TECH9; 
Listing 4.4: Mplus input for the Monte Carlo study using the multi-group
approach with the population treatment probability in order to estimate and
test the average treatment effect.
For the second version of the test, the MONTECARLO statement is not feasi-
ble because the values for the relative group sizes change between replications.
It is therefore necessary to write an input file and save the corresponding
results for every replication. Listing 4.5 provides an example for the ver-
sion using the sample proportion of cases in group two. Line 11 specifies
the average treatment effect with a non-linear constraint according to Equa-
tion 4.16. The results for the average treatment effect are again found under
New/Additional Parameters labeled AE. The results are summarized over
all replications using R.
4.3.4 Results
The performance of the three methods is evaluated with regard to the bias of
the average effect estimator as well as the bias of the standard error estimator
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1 DATA: FILE = mcrep1.dat;
2 VARIABLE: NAMES ARE Y1 Y2 Z1 Z2 G;
3 GROUPING IS X (1 = G1 2 = G2);
4 ANALYSIS: TYPE = MEANSTRUCTURE;
5 MODEL: XI BY Z1 Z2; ETA BY Y1 Y2; ETA ON XI;
6 MODEL G1: ETA ON XI (BE1);
7 MODEL G2: ETA ON XI (BE2);
8 [XI] (MXI2);
9 [ETA] (AL2);
10 MODEL CONSTRAINT: NEW(AE);
11 AE = AL2 + (BE2 - BE1) * MXI2 * 0.51;
12 OUTPUT: TECH1;
13 SAVEDATA: RESULTS = mcrep1.res; 
Listing 4.5: Mplus input for the Monte Carlo study using the multi-group
approach with the relative group size from the sample in order to estimate
and test the average treatment effect.
for the average effect. Assessing bias of a parameter estimator is usually done
by subtracting the population value from the average over all estimates and
dividing the result by the population value. Because the population value of
the average effect is zero, bias is assessed simply by evaluating the average
over all estimates. Table 4.1 gives the results for the three methods and all
parameter combinations.
All three models yield averages that are sufficiently close to the true
population value of zero. Hence, for the given parameter combinations, all
three methods provide unbiased estimates of the average effect. The SEM
approach extended to random slopes provides an unbiased estimate of the
average treatment effect. Also, both multi-group models provide unbiased
estimates, despite the deviations from normality of the distributions of several
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variables. Ignoring the fact that the relative group size is a random variable
does not seem to negatively effect the average effect estimation (version two
of the multi-group test).
Standard error bias is assessed by subtracting the population standard
error value (the standard deviation of all average effect estimators) from the
average standard error value and dividing this number by the population
standard error value and multiplying by 100. Table 4.2 gives the results for
the three methods and all parameter combinations.
All three models yield negligible standard error biases for small, medium
and large interaction effects. The standard error biases of the single-group
model as well as the standard error biases of the multi-group model with the
population treatment probability are acceptable for all parameter combina-
tions (values less than five). Only the multi-group model using the estimated
treatment probability yields inflated standard error biases for very large in-
teraction effects (β3 = 1.5, 3, and 10). The stronger the dependency of the
treatment on the latent covariate the larger the inflation. The sample sizes
does not seem to have an effect on this inflation.
4.3.5 Monte Carlo Study with Unequal Group Sizes
In the second Monte Carlo study the threshold parameter of Equation 4.10
is set to l0 = 1 and the resulting assignment probabilities are P (X=1) ≈
0.7 and P (X=2) ≈ 0.3. These values are computed by using numerical
integration. Consequently, the expected proportion of cases in the treatment
group is less than a third of the total sample size.
The performance of the average treatment effect estimators is studied with
a smaller design than in the previous Monte Carlo study. The reason for this
is the computational demand of the SEM approach extended to random slope
CHAPTER 4. NON-RANDOMIZED DESIGNS 128
Table 4.1
Averages of the Average Effect Estimators Over All 1000 Replications for the
Three Methods. Varied Parameters are: Interaction, Correlation Between
Treatment and ξ (moderate or strong), and Sample Size (400 or 1000).
Interaction
0 0.2 0.5 0.8 1.5 3 10
Singlegroup model extended to random slopes
moderate
400 0.00 0.00 −0.01 −0.01 −0.00 0.01 0.01
1000 −0.00 −0.00 0.00 −0.00 −0.00 0.01 0.00
strong
400 −0.00 −0.00 −0.00 −0.01 −0.00 0.00 −0.00
1000 −0.00 −0.00 −0.00 0.00 −0.01 0.00 0.01
Multigroup model with population treatment probability
moderate
400 0.00 −0.00 −0.01 −0.01 −0.00 −0.01 −0.01
1000 −0.00 −0.00 0.00 −0.00 −0.00 0.00 −0.01
strong
400 −0.01 −0.00 −0.01 −0.02 −0.01 −0.01 −0.02
1000 −0.00 −0.00 −0.00 −0.00 −0.01 −0.01 −0.01
Multigroup model with estimated treatment probability
moderate
400 0.00 −0.00 −0.01 −0.01 −0.00 −0.01 −0.00
1000 −0.00 −0.00 0.00 −0.00 −0.00 −0.00 −0.00
strong
400 −0.01 −0.00 −0.01 −0.02 −0.01 −0.01 −0.03
1000 −0.00 −0.00 −0.00 −0.00 −0.01 −0.01 −0.01
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Table 4.2
Standard Error Biases of the Three Models. Varied Parameters Are: In-
teraction, Correlation Between Treatment and ξ (moderate or strong), and
Sample Size (400 or 1000).
Interaction
0 0.2 0.5 0.8 1.5 3 10
Singlegroup model extended to random slopes
moderate
400 −1.80 −3.17 −0.80 −3.52 −3.21 −1.07 1.44
1000 −1.01 −1.32 −2.17 −2.45 −0.72 −2.99 −0.31
strong
400 −3.94 −3.99 3.58 −1.71 −1.34 −0.55 1.89
1000 −0.79 −1.86 −0.43 1.45 −1.85 −0.86 −0.91
Multigroup model with population treatment probability
moderate
400 −2.22 −3.28 −1.10 −3.20 −2.75 −1.88 0.61
1000 −1.01 −1.48 −2.03 −2.34 −0.49 −1.16 −0.24
strong
400 −4.33 −3.97 3.86 −0.19 −4.62 0.04 5.75
1000 −1.01 −2.29 0.11 0.10 −1.66 1.87 −0.97
Multigroup model with estimated treatment probability
moderate
400 −2.23 −3.46 −1.62 −5.22 −6.26 −6.02 −6.10
1000 −0.90 −1.53 −2.95 −3.35 −3.79 −7.69 −6.49
strong
400 −4.32 −3.87 2.87 −3.03 −7.73 −9.80 −12.09
1000 −1.00 −1.94 −1.25 −1.10 −5.19 −8.83 −15.12
Note. Values with an absolute value larger than five are printed bold and are
considered severely biased.
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due to numerical integration. The only factor included in the design of the
Monte Carlo study here is the interaction effect between X and ξ. The total
sample size is set to N = 400. The slope parameter is set to l1 = −1. The
corresponding dependency of X on ξ is Corr(IX=2) ≈ 0.39 and is considered
to be moderate. The values of β3 are systematically varied between the same
values as in the previous study. The effect size of the interaction is again
considered to be equivalent to the corresponding parameter values.5
Data are again analyzed with the three methods described in the previous
section. The input for the single-group SEM approach extended to random
slope is exactly the same (Listing 4.3). For the two multi-group versions the
values of the assignment probability for treatment is set to either the true
population value
P (X=2) ≈ 0.303 (line 11 in Listing 4.4) or the sample value (line 11 in
Listing 4.5).
Results
The performance of the three methods is evaluated with regard to the bias of
the average effect estimator as well as the bias of the standard error estimator
for the average effect. Because the population value of the average effect is
zero, bias is assessed by evaluating the average over all estimates. Table 4.3
gives the results for the three methods.
All three models yield averages that are sufficiently close to the true
population value of zero. Hence, all methods provide unbiased estimates
of the average effect for the given case of unequal treatment probabilities.
5The norm to determine effect size is again the variance of η in group one as it would
be without a dependency of X on ξ (i. e., Var(η |X=1) = 1). The expected variance of η
in group one for the given dependency of X on ξ is actually Var(η |X=1) = .93.
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Table 4.3
Estimation Biases of the Second MC Study for the Models Including
the Interaction Given a Moderate Treatment Latent Covariate Cor-
relation.
Interaction
0 0.2 0.5 0.8 1.5 3 10
Singlegroup model extended to random slopes
0.00 0.01 0.00 0.01 0.01 0.03 0.01
Multigroup model with population treatment probability
−0.00 0.00 −0.00 0.00 −0.01 −0.00 −0.05
Multigroup model with estimated treatment probability
−0.00 0.00 −0.00 0.00 −0.01 −0.00 −0.04
The SEM approach extended to random slopes gives an unbiased estimate
of the average treatment effect. It performs well for the given examples with
regard to estimating and testing the average treatment effect. Both multi-
group models provide unbiased estimates. Note again that the distribution
of several variables in the given examples deviate from normality. Ignoring
the fact that the relative group size is a random variable does not seem bias
the average effect estimation.
Standard error bias is again assessed by subtracting the population stan-
dard error value (the standard deviation of all average effect estimators) from
the average standard error value and dividing this number by the population
standard error value and multiplying by 100. Table 4.4 on the following page
gives the results for the three methods.
All three models again yield negligible standard error biases for small,
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Table 4.4
Standard Error Biases of the Second MC Study for the Models Including
the Interaction Given a Moderate Treatment Latent Covariate Correla-
tion.
Interaction
0 0.2 0.5 0.8 1.5 3 10
Singlegroup model extended to random slopes
−1.87 −1.54 −2.32 0.57 −0.94 −1.56 −4.03
Multigroup model with population treatment probability
−1.85 −2.15 −1.45 1.71 −3.01 −0.13 −3.97
Multigroup model with estimated treatment probability
−1.99 −2.17 −2.03 0.12 −4.85 −4.15 −8.39
Note. Values with an absolute value larger than five are printed bold and are
considered severely biased.
medium and large interaction effects. The standard error biases of the single-
group model as well as the standard error biases of the multi-group model
with the population treatment probability are acceptable for all parameter
combinations. The multi-group model using the sample treatment proba-
bility yields standard error biases that are acceptable even for very large
interaction effects β3 = 1.5 and 3. This was not the case in the last Monte
Carlo study. The standard error biases of the multi-group model using the
sample treatment probability are inflated only for the (very) extreme case
β3 = 10.
The descriptive statistics of the results of the Monte Carlo study for the
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balanced as well as the Monte Carlo study for the unbalanced design show
that all three models are applicable to test average treatment effects if small
or medium interaction effects are present. Because most interaction effects
found in the social sciences are small or medium, the conclusion is that
there is usually no need to apply the computationally more demanding SEM
approach extended to random slopes. Furthermore, for the given examples,
the multiple group approach has proved to be applicable despite the described
deviations from normality of several variables. This finding is in line with
Bollen (1989, p. 126–127), Johnston (1984, p. 281–285), and Jo¨reskog (1973,
p. 94)).
It is clear however, that the design of the presented Monte Carlo studies
is quite small, limiting the generalization of the conclusions drawn from it.
An important extension is to include more than two treatment (groups) and
a multivariate covariate in order to test, how the outlined procedures perform
with regard to analyzing average treatment effects. It was also mentioned
that one advantage of the multiple group approach is to model group specific
variances of the structural residual. However, the case where the residual
variances differ between groups (i. e., Var(ζ |X=1) 6= Var(ζ |X=1)) was not
considered in the Monte Carlo studies. It might be possible to extend the
random slope approach in order to model different residual variances. Com-
paring the different approaches with regard to analyzing average treatment
effects is interesting because Steyer (2005) developed models to test not only
average treatment effects but also individual treatment effects, and these
models may imply different residual variances.
Chapter 5
Discussion and Conclusion
In the following section I discuss why I believe that an analysis of average or
main effects plays an important role in the analysis of treatment effects, even
if interaction effects are present. Given that interaction effects are present,
the effect of a treatment depends on covariates. An analysis of these interac-
tion effects therefore provides detailed information. For each (combination
of) covariate value(s), it is possible to compute the predicted difference be-
tween the treatment groups with respect to the dependent variable. Inter-
action effects provide information on how the conditional treatment effects
vary depending on the covariates.
Some statisticians advocate not to interpret average (or main) effects in
the presence of interactions, because an average effect does not adequately
represent the variability of the conditional (or simple) effects of the treat-
ment. The analysis of average effects in non-orthogonal designs is even more
in dispute, mostly because the partitioning of the sums of squares is still
controversial. It is certainly not my intention to argue against the analy-
sis of interaction effects, because they are very informative and because the
theoretical focus of most studies is on them rather than on the average effects.
134
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However, even if interaction effects are present, many researchers con-
sider the information about the average effect as informative. This can be
seen in the long struggle to find an adequate analysis of non-orthogonal de-
signs (Carlson & Timm, 1974; Gosslee & Lucas, 1965; Keren & Lewis, 1976)
and the related debate documented in the Psychological Bulletin. Differ-
ent perspectives and approaches may be found for example in Snee (1973);
M. H. Kutner (1974); Speed et al. (1978). Some of the approaches, espe-
cially the four types of partitioning the sums of squares, are widely used
and implemented in most statistical software for ANOVA and multiple lin-
ear regression. This indicates that there must be substantial interest in the
analysis of average effects within the research community and applied fields.
As mentioned before, there are several methodological articles that focus
on the analysis of interaction effects and average effects of a treatment, espe-
cially in the behavioral sciences (see, e. g., Aiken & West, 1991; West et al.,
1996). B. O. Muthe´n and Curran (1997) describe a latent-growth framework
to estimate the average effect of a treatment, if the treatment interacts with
the initial status, which is the measure of the outcome variable before onset
of the treatment.
Average treatment effects also play an important role in the theory of
causality (see, e. g., Rubin, 1974) and the analysis of quasi-experimental
studies (see, e. g., Shadish et al., 2002) or observational studies (Rosenbaum,
2002). In the literature on average causal effects much effort is spent on
developing tests that aim to reduce bias in estimating average treatment
effects. In fact, procedures such as the propensity score analysis (Rosenbaum
& Rubin, 1984) yield (only) an estimate of the average effect of a treatment
(and not of the interaction effects).
The key principle of methods based on the propensity score is to avoid the
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modeling of a full regression equation (including interaction terms). Instead,
the covariates are used to model (and estimate) the propensity scores (the
probability of an observational unit being assigned to one of the treatment
conditions). The observational units are then matched based on the (esti-
mated) propensity scores. If certain conditions hold, then the outcome can
be interpreted as an estimate of the average causal effect of the treatment
(see, e. g., Rosenbaum & Rubin, 1984).
Steyer et al. (2002) discusses conditions that have to hold so that the
average treatment effect estimated by the outlined method of this thesis
can be interpreted as an unbiased estimate for the average causal effect in
the sense of Rubin (1974); Rubin (1978). By applying the outlined method
to designs that were traditionally analyzed with ANOVA or multiple linear
regression methods, it is possible to compare them to studies analyzed with
propensity score methods.
So far it was mentioned that many researchers consider average effects
important (at the presence of interaction effects). From a data analysis per-
spective, average effects may provide a good starting point. Consider a study
that investigates the effect of a treatment depending on several categorical
and continuous covariates. Even with just a few categorical and continuous
covariates, the number of possible effects to analyze becomes quite large. If
there is no theory that leads to a-priory hypotheses, it may seem arbitrary
which terms of the regression equation to test for significance.
However, a hypothesis about the average treatment effect — no matter
how complicated the (underlying) regression equation might be — is always
a straightforward hypothesis. Because the degrees of freedom of such a hy-
pothesis are equal to the number of the involved average effects, the power
of this test will be larger than the power of tests of more detailed effects. In
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this way, a measure of the average treatment effect serves the principle of
simplicity.
I certainly agree that average (treatment) effects do not represent the vari-
ability of the treatment effects, if interactions with covariates are present. I
note however, that conditional effects (or simple effects in ANOVA) which
form the interactions also represent averages: the averages of the individ-
ual effects of the observational units sharing the same covariate value. It
is apparent that interaction effects do not represent the variability of these
individual effects. Designs and statistical methods to analyze individual ef-
fects are described in the literature on the analysis of individual differences.
For example, Steyer (2005) discussed the analysis of individual and average
causal effects.
Average effects are also important in applied settings. In all cases where
the members of a population can not be treated individually, a decision about
which treatment to apply to the population should be based on the average
treatment effect. Consider a study of a new educational program. Some
students may benefit more from the new program than others. The average
effect provides valuable information in order to decide whether to implement
the program for a school district or any other population. The example can
be transferred to other cases, such as the patients of a clinic or the employees
of a firm.
Average effects are important for rankings. Consider a comparison of two
clinics with regard to their performance of treating a disorder. The effect of
the treatment may depend on a pretest, such as the severity of the disorder
or the neediness for a treatment. The average treatment effect provides a
useful measure to compare the overall performance of clinic A to clinic B, if
the patients of the clinics differ in their covariate values.
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5.1 Conclusion
A major improvement in the analysis of treatment effects was the applica-
tion of multiple linear regression methods that use centered covariates. This
allowed to (simultaneously) estimate and test interaction effects as well as
average treatment effects for designs including continuous covariates (see,
e. g., Aiken & West, 1991; West et al., 1996). In this thesis, I have defined
the average treatment effect and shown how multiple linear regression, or to
be more specific the general linear model, can be applied to simultaneously
analyze interaction and average treatment effects without the need to center
the covariates. The method uses the general linear hypothesis and is more
flexible than the centering approach especially for the case that more than
one covariate is involved and higher order interactions are considered.
An important result of this thesis is that multiple linear regression meth-
ods (whether centering is applied or the general linear hypothesis) are only
applicable to test average treatment effects, if the means (and higher or-
der moments) of the covariates that appear in the hypotheses about average
treatment effects are known. If these covariate means, have to be estimated
from the sample, is was argued that maximum likelihood methods should be
used to test average treatment effects especially if medium or large interac-
tion effects are present.
Because in many studies it will be the case that the covariate means
have to be estimated, the proposed maximum likelihood method is an im-
portant improvement for the analysis of treatment effects. I show that the
test can be implemented in existing statistical software programs that use
maximum likelihood methods, such as LISREL and Mplus. It was also shown
that the procedure is applicable to unbalanced designs usually analyzed by
non-orthogonal ANOVA methods.
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In the social sciences, the covariates are oftentimes measured with mea-
surement error. The appropriate method to address measurement errors of
covariates is to apply structural equation modeling (Bollen, 1989). In this
thesis, two structural equation modeling approaches are discussed that allow
the modeling of interactions between treatment and latent covariates. For
the standard multiple group model (section 3.3.1) it was shown how to imple-
ment the test for the average treatment effect. Two cases were distinguished
depending on whether randomization was implemented in the research de-
sign or not. A method to determine power with regard to detecting average
treatment effects was described. For the structural equation modeling ap-
proach extended to random slopes, which allows the modeling of interactions
between continuous (latent) variables, it was also shown how to implement
the test of the average treatment effect.
Practical recommendations The Monte Carlo study for the manifest
covariate implies that common regression analysis (centering and general
linear hypothesis approach) may be used even if the mean of the covariate is
only estimated as long as there is only a small interaction between treatment
and covariate. If medium or large interaction effects are present, then the
maximum likelihood approach should be applied in order to test the average
treatment effect.
If covariates are measured with a measurement error, latent variable mod-
eling should be applied (Bollen, 1989). For randomized designs, the stan-
dard (multi-group) latent variable framework should be applied with the
described restrictions in order to estimate and test average treatment effects.
For non-randomized designs the Monte Carlo studies have shown that the
SEM approach extended to random slopes as well as the standard multi-
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group approach perform equally well for the chosen examples. Only for very
large interaction effects did the multi-group approach with the estimated
treatment probabilities yield biased standard errors while the random slope
approach performed well.
It is clear however, that more testing is required involving larger designs
that include cases with multivariate (latent) covariates and more than two
treatment groups. For the given examples, however, it can be concluded that
the described outline provides a unified approach to estimate and test average
(or main) treatment effects, as well as interaction effects for interventional
studies. Steyer and Partchev (2007) are developing a user friendly software
including the methods described in this dissertation.
Appendix A
Mplus Inputs
 
1 DATA: FILE IS DATA.dat;
2 VARIABLE: NAMES ARE Y X Z;
3 USEVARIABLES ARE Y Z1 Z2 C1 C2 Z1C1 Z2C1 Z1C2 Z2C2;
4 DEFINE: Z1=0; Z2=0; C1=0; C2=0;
5 IF(Z EQ 1)THEN Z1 = 1; IF(Z EQ 2)THEN Z2 = 1;
6 IF(X EQ 1)THEN C1 = 1; IF(X EQ 2)THEN C2 = 1;
7 Z1C1 = Z1 * C1; Z2C1 = Z2 * C1;
8 Z1C2 = Z1 * C2; Z2C2 = Z2 * C2;
9 ANALYSIS: TYPE = MEANSTRUCTURE;
10 MODEL: Y ON Z1 Z2
11 C1(b3)
12 C2(b4)
13 Z1C1(b5)
14 Z2C1(b6)
15 Z1C2(b7)
16 Z2C2(b8);
17 [Z1](mZ1);
18 [Z2](mZ2);
19 [Y C1 - Z2C2];
20 MODEL CONSTRAINT:
21 b3 = - b5 * mZ1 - b6 * mZ2;
22 b4 = - b7 * mZ1 - b8 * mZ2; 
Listing A.1: Mplus input for the ANOVA example in section 2.5
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 
1 DATA: FILE IS DATA.dat;
2 VARIABLE: NAMES ARE Y X Z1 Z2;
3 USEVARIABLES ARE Y Z1 Z2 Z1Z2
4 C1 Z1C1 Z2C1 Z1Z2C1
5 C2 Z1C2 Z2C2 Z1Z2C2;
6 DEFINE: Z1Z2 = Z1 * Z2; C1 = 0; C2 = 0;
7 IF(X EQ 1)THEN C1 = 1; IF(X EQ 2)THEN C2 = 1;
8 Z1C1 = Z1*C1; Z2C1 = Z2*C1; Z1Z2C1 = Z1*Z2*C1;
9 Z1C2 = Z1*C2; Z2C2 = Z2*C2; Z1Z2C2 = Z1*Z2*C2;
10 ANALYSIS: TYPE = MEANSTRUCTURE;
11 MODEL: Y ON Z1 Z2 Z1Z2
12 C1(b4)
13 Z1C1(b5)
14 Z2C1(b6)
15 Z1Z2C1(b7)
16 C2(b8)
17 Z1C2(b9)
18 Z2C2(b10)
19 Z1Z2C2(b11);
20 [Y C1 - Z1Z2C2];
21 [Z1](mZ1);
22 [Z2](mZ2);
23 [Z1Z2](mZ1Z2);
24 MODEL CONSTRAINT:
25 b4 = - b5*mZ1 - b6*mZ2 - b7*mZ1Z2;
26 b8 = - b9*mZ1 - b10*mZ2 - b11*mZ1Z2; 
Listing A.2: Mplus input for the centering example described in section 2.6
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 
1 DATA: FILE = data.dat;
2 VARIABLE: NAMES = Y1 Y2 Z1 Z2 X;
3 GROUPING = X (1=G1 2=G2);
4 ANALYSIS: TYPE = MEANSTRUCTURE;
5 MODEL: XI BY Z1 Z2;
6 ETA BY Y1 Y2;
7 [XI@0];
8 ETA ON XI; 
Listing A.3: Multi-group SEM to analyze treatment effects for a randomized
two-group design modeling an interaction between treatment and a latent
covariate (see section 3.4).
 
1 DATA: FILE = data.dat;
2 VARIABLE: NAMES = Y1 Y2 Z1 Z2 X;
3 GROUPING = X (1=G1 2=G2);
4 ANALYSIS: TYPE = MEANSTRUCTURE;
5 MODEL: XI BY Z1 Z2;
6 ETA BY Y1 Y2;
7 [XI@0];
8 ETA ON XI;
9 MODEL G1: ETA ON XI (B1);
10 MODEL G2: ETA ON XI (B2);
11 MODEL CONSTRAINT:
12 NEW (INT);
13 INT = B2 - B1; 
Listing A.4: This is the same input as in Listing A.3 with the additional test
for the interaction in lines 9 to 13.
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 
1 DATA: FILE = data.dat;
2 VARIABLE: NAMES = Y1 Y2 Z1 Z2 X;
3 GROUPING = X (1=G1 2=G2);
4 ANALYSIS: TYPE = MEANSTRUCTURE;
5 MODEL: XI BY Z1 Z2;
6 ETA BY Y1 Y2;
7 [Z1@0];
8 [Y1@0];
9 ETA ON XI;
10 MODEL G1: [XI] (MXI);
11 [ETA] (AL1);
12 ETA ON XI (BE1);
13 MODEL G2: [XI] (MXI);
14 [ETA] (AL2);
15 ETA ON XI (BE2);
16 MODEL CONSTRAINT:
17 NEW(AE);
18 AE = AL2 - AL1 + (BE2 - BE1) * MXI; 
Listing A.5: This is an example of an Mplus input to test the average treat-
ment effect. The difference to the Mplus input given in Listing A.3 is the
scaling of the latent variables. The test of the average treatment effect re-
quires additional statements (see section 3.4.1).
 
1 DATA: FILE = pop.dat;
2 TYPE = MEANS FULLCOV;
3 NGROUPS = 2;
4 NOBSERVATION = 1000 1000;
5 VARIABLE: NAMES = Y1 Y2 Z1 Z2;
6 ANALYSIS: TYPE = MEANSTRUCTURE;
7 MODEL:
8 XI BY Z1-Z2; ETA BY Y1-Y2;
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9 ! XI BY Z1-Z2@1; ETA BY Y1-Y2@1;
10 [XI@0];
11 ETA ON XI;
12 ! ETA ON XI (1);
13 ! [ETA@0];
14 OUTPUT: STANDARDIZED RESIDUAL; TECH1; 
Listing A.6: This input is described throughout section 3.5, discussing power
in randomized designs.
 
1 DATA: FILE = pop.dat;
2 TYPE = MEANS FULLCOV;
3 NGROUPS = 2;
4 NOBSERVATION = 1000 1000 ;
5 VARIABLE: NAMES = Y1 Y2 Z1 Z2;
6 USEVARIABLES = Y1 Y2;
7 ANALYSIS: TYPE = MEANSTRUCTURE;
8 MODEL:
9 ! ETA by Y1-Y2;
10 ETA by Y1-Y2@1;
11 ! [ETA@0];
12 OUTPUT: STANDARDIZED RESIDUAL; TECH1; 
Listing A.7: The input for the model ignoring ξ. See section 3.5.4 for a
description of this Input.
 
1 MONTECARLO:
2 NAMES ARE Y1 Y2 Z1 Z2; NGROUPS = 2;
3 NOBSERVATION = 400 400 ; NREPS = 1000 ;
4 SEED = 36555654 ;
5 REPSAVE = ALL; SAVE = mcrep*.dat;
6 MODEL MONTECARLO:
7 XI BY Z1-Z2@1; XI@1; Z1-Z2@0.5; [XI@0 Z1-Z2@0];
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8 ETA BY Y1-Y2@1; Y1-Y2@0.5; [Y1-Y2@0];
9 MODEL MONTECARLO-X1:
10 ETA ON XI@0.707106781186548;
11 ETA@0.5; [ETA@0.2];
12 MODEL MONTECARLO-X2:
13 ETA ON XI@0.907106781186548;
14 ETA@0.5; [ETA@0.2];
15 ANALYSIS: TYPE = MEANSTRUCTURE;
16 MODEL:
17 XI BY Z1-Z2; ETA BY Y1-Y2;
18 [XI@0];
19 ETA ON XI;
20 MODEL X1:
21 ETA ON XI (p1);
22 MODEL X2:
23 ETA ON XI (p2);
24 MODEL CONSTRAINT:
25 NEW (int);
26 int = p2 - p1; 
Listing A.8: The Mplus input for the Monte Carlo study described in sec-
tion 3.5.2 is given here.
 
1 MONTECARLO:
2 NAMES ARE Y1 Y2 Z1 Z2; NGROUPS = 2;
3 NOBSERVATION = 500 500; NREPS = 1000 ;
4 SEED = 13155732;
5 REPSAVE = ALL; SAVE = mcrep*.dat;
6 MODEL MONTECARLO:
7 XI BY Z1-Z2@1; XI@1; Z1-Z2@0.5; [XI@0 Z1-Z2@0];
8 ETA BY Y1-Y2@1; Y1-Y2@0.5; [Y1-Y2@0];
9 MODEL MONTECARLO-X1:
10 ETA ON XI@0; ETA@1; [ETA@0.2];
APPENDIX A. MPLUS INPUTS 147
11 MODEL MONTECARLO-X2:
12 ETA ON XI@0; ETA@1; [ETA@0.4];
13 ANALYSIS: TYPE = MEANSTRUCTURE;
14 MODEL:
15 XI BY Z1-Z2; ETA BY Y1-Y2;
16 [XI@0];
17 ETA ON XI; 
Listing A.9: The Mplus input for the Monte Carlo study described in sec-
tion 3.5.4.
 
1 DATA: FILE = mcreplist.dat;
2 TYPE = MONTECARLO;
3 VARIABLE: NAMES = Y1 Y2 Z1 Z2 X;
4 GROUPING = X (1 = G1 2 = G2);
5 USEVARIABLES = Y1 Y2;
6 ANALYSIS: TYPE = MEANSTRUCTURE;
7 MODEL: ETA BY Y1-Y2; 
Listing A.10: The Mplus input for the Monte Carlo study described in sec-
tion 3.5.4. This input is for the model without the latent covariate and
tau-congeneric measurement models and requires previously generated data
(e. g., from the input given in Listing A.9).
Appendix B
R Programs
Listing B.1 gives a program, that computes the power as described in the
main text (see, e. g., Chapter 3.5). This program is written for the statisti-
cal language and programming environment R (R Development Core Team,
2006). The values of chi.square.diff have to be obtained as described in
the text for a total sample size samplesize.orignial. Given alpha, df,
and samplesize.desired the program computes the power.
 
1 q <- qchisq(1 - alpha, df)
2 power <- 1 - pchisq(q, df, ncp = chi.square.diff *
3 samplesize.desired / samplesize.original) 
Listing B.1: A R program to compute power.
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 
1 mc.sample <- function(filename) {
2 xi <- rnorm(N, mean=0, sd=1)
3 x <- 1 + (runif(N) <= 1 / (1 + exp(l0 + l1*xi)))
4 eta <- 0 + 0 * (x==2) + sqrt(0.5) * xi +
5 b3 * xi * (x==2) + rnorm(N, 0, sqrt(0.5))
6 z <- rep(1, N) %o% c(0,0) + xi %o% c(1,1) +
7 cbind(rnorm(N, 0, sqrt(0.5)), rnorm(N, 0, sqrt(0.5)))
8 y <- rep(1, N) %o% c(0,0) + drop(eta) %o% c(1,1) +
9 cbind(rnorm(N, 0, sqrt(0.5)), rnorm(N, 0, sqrt(0.5)))
10 write.table(cbind(y, z, x), file = filename, sep = ",",
11 row.names=FALSE, col.names=FALSE,
12 quote=FALSE)
13 }
14 writeLines(paste("mcrep", 1:1000, ".dat", sep = ""),
15 "mcreplist.dat", "\n")
16 set.seed(310001317)
17 lapply(readLines("mcreplist.dat"), function(fn)
18 mc.sample(fn)) 
Listing B.2: R input to generate data for Monte Carlo studies. The assign-
ment probabilities are computed by a logistic function of the latent covariate.
Appendix C
Proofs
C.1 Ignoring the Covariate
Proof of Equations 2.17 and 2.18:
The regression of Equation 2.1 is repeated here:
E (Y |X,Z) = β0 + β1Z + β2X + β3ZX (C.1)
To compute the two group means of Y we need the regression of Y on X.
The following derivation uses some properties of regression and conditional
expected values, which can be found for example in Bauer (1981).
E (Y |X) = E [E (Y |X,Z) |X]
= E [β0 + β1Z + β2X + β3ZX |X]
= β0 + β1 E (Z |X) + β2X + β3 E (ZX |X)
= β0 + β1 E (Z |X) + β2X + β3X E (Z |X)
(C.2)
The two group means of Y result in:
E (Y |X=0) = β0 + β1 E (Z |X=0)
E (Y |X=1) = β0 + β1 E (Z |X=1) + β2 + β3 E (Z |X=1).
(C.3)
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C.2 Power for Randomized Designs
The following proof shows that, given the parameter settings in section 3.5.1,
the variance of the latent outcome is always one (see Equation 3.37 on
page 74):
Proof.
Var (1)(η) = Var (1)(E (η | ξ)) + Var (1)(ζ)
= Var (1)(α(1) + β(1)ξ) + Var (1)(ζ)
= β(1)
2
Var (1)(ξ) + Var (1)(ζ)
=
1− Var (1)(ζ)
Var (1)(ξ)
Var (1)(ξ) + Var (1)(ζ)
= 1.
(C.4)
As a consequence the correlation of ξ and η is equal to the structural
slope in the first group.
Proof.
Corr (1)(ξ, η) =
Cov (1)(ξ, η)
Std(ξ) Std (1)(η)
= Cov (1)(ξ, α(1) + β(1)ξ + ζ)
= β(1)Var(ξ)
= β(1)
(C.5)
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